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Abstract 
The project of which this thesis is a part of is aimed at developing a comprehensive 
framework for health and non-health public expenditures to confront the HIV epidemic. 
Within the framework of a regression model, the main drivers of the domestic public 
expenditures on HIV and AIDS is identified, and these expenditures is predicted where data 
on this variable is missing. The model analyzes the factors associated with government 
disbursements related to HIV/AIDS in low- and middle-income countries, using information 
from the National AIDS Spending Assessments at the country level. It considers the impact 
of demographic and non-demographic variables for both health and non-health (i.e. 
education, advocacy and policy development, the judiciary system and human rights) 
expenditures. The results are meant to provide essential empirical information on financial 
resources. Identifying the factors associated with domestic public expenditure is important 
when examining the countries’ ability to take on a greater share of the financial burden to 
sustain a response to the HIV epidemic.
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1. Introduction 
Keeping track of the resource flow addressed to HIV (Human Immunodeficiency Virus) 
AIDS (acquired immunodeficiency syndrome), and the resources available is the first step 
when it comes to examining the effectiveness of the aid and deployment for an effective 
response. Until recently, estimates for HIV expenditures have only covered spending in the 
health sector (UNAIDS, 2006: 234) Expenditures on HIV and AIDS do not only consist of 
health expenditures, in fact it is estimated that more than half of the total amount required for 
the AIDS response each year should go to prevention (UNAIDS, 2006: 226). Expenditures 
on HIV and AIDS also include treatment and care, in which antiretroviral therapy (ART) 
requires the greatest share of money, support for orphans and vulnerable children, 
programme support and infrastructure, and human resources. Resource tracking is essential 
when determining the gap between resources available and resources needed. This analysis 
often reveals severe misallocations of the money. Making this visible is not only important 
when it comes to decision making, but also when it comes to policy dialogue and advocacy. 
For example, the Global Fund requires 10% to 20% of counterpart financing over the 
proposal term if the recipient is a lower-middle income country in round 7 (Global Fund, 
2007) 
1.1 Problem statement 
Tracking flows allocated to HIV and AIDS is complex work as they come from various 
sources, the main ones being bilateral, multilateral, private and domestic sources. The focus 
of this project is to identify the level of domestic public expenditure, it is an important part 
of resource tracking; it currently consists of about 30% of the available resources for HIV 
and AIDS on a global level. Identifying the governments level of domestic spending gives 
an indication on its national commitment on HIV an AIDS. It is also essential when 
prioritizing aid recipients; when funds to HIV and AIDS are scarce they should be allocated 
to the countries needing them the most. All countries and donors should give a higher 
priority to reducing the burden placed on low-income countries. Knowing the level of 
spending of a country is the first step in examining the countrys ability to take on a grater 
share of the financial burden to sustain a response to the HIV epidemic. Furthermore, donor 
flows are shown to be highly volatile and unpredictable (Lewis, 2005:12). Where it is 
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possible, relying more on the countries own resources and thus having a more predictable 
funding, will enable the government to have longer term projects.    
 
One of the main problems in addressing the spending is the lack of information. Not all 
countries have a system to record their spending on HIV and AIDS, and if they do, it is not 
always obvious how to interpret the data. This project will on the one hand contribute to 
creating a database for government spending, and on the other hand to develop a model 
including economic, demographic and epidemiological factors among its explanatory 
variables. The model will identify the main drivers of the spending to make reliable 
estimates and predictions where data is not available. Previous work by the Resource Flows 
Project projected domestics government expenditure related to STD/HIV/AIDS largely 
based on GDP growth (Dalen and Reijer, 2006). Identifying the main explanatory factors for 
changes in domestic public expenditures will make the projection modelling more 
sophisticated and accurate, and provide predictions were no data is available. Currently we 
have information for 81 countries from 2004; the goal is to have predictions for 55 other 
countries. That is, the best data available for HIV expenditures from countries themselves 
will be used to make an econometric model to fill in the gaps for the 55 countries that do not 
have data available. Then, this total of 136 countries will give the estimated level of HIV 
expenditures in low- and middle-income countries. 
1.2 Previous studies 
According to UNAIDS, the Resource Flows Project was engaged to estimate and project 
resource flows from donor governments and governments and NGOs in developing countries 
and countries in transition. They have projected domestic public expenditures from 2005 to 
2007 (Dalen and Reijer, 2006), with an estimated 3,062,675 USD spent by governments in 
2005 in developing countries and countries in transition. They assumed that projected 
funding levels grow according to the set longitudinal trend. Therefore, for projections in 
countries with no secondary information, the growth in funds in 2005 and 2006 is 
completely driven by developments in national income (GDP). The Resource Flows Project 
used the same database as in this study (UNAIDS, 2006), except for the additional reports 
and update received after the publication of their paper. 
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2. Background information 
2.1 Overview of the epidemic 
HIV is a retrovirus that causes AIDS, which leads to failing immune systems making 
humans vulnerable to life-threatening opportunistic infections. Today, an estimated 33.6 
million [33.4 million-46.0 million] people worldwide are affected with HIV according to the 
UNAIDS report on the global AIDS epidemic (UNAIDS, 2006:9). The nature of the 
epidemic is classified in three different categories: low level, concentrated or high level, 
emerging or advanced (UNAIDS, 2006:234). The transmission patterns vary among 
countries. Unlike Western Europe where most infections occur in men who have sex with 
men (MSM), heterosexual intercourse is the greatest trigger in Sub Saharan African 
countries. The three main transmission routes are unprotected sexual intercourse (as 
mentioned above), contaminated needles, and transmission from an infected mother to her 
baby at birth, or through breast milk (vertical transmission). 
 
Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health 
Organization (WHO) estimate that AIDS has killed more than 25 million people since it was 
first recognized on December 1, 1981, making it one of the most destructive pandemics in 
recorded history (UNAIDS, 2006:4). The fact that HIV is transmitted through body fluids 
makes it prone to stigmatization and challenges the response to the pandemic.  
 
Countries need sustained and predictable funding that increases over time because of the 
long term nature of the epidemic. 5.5 billion people, or 85% of the worlds population live in 
the 148 countries classified as low- and middle income countries in 2005, and more than 
90% of people living with HIV are from these countries (UNAIDS, 2006). The estimated 
annual funding for the AIDS response in that year was USD 8.3 billions, compared to the 
estimated need of about USD 12 millions. That leaves a gap of about USD 4 millions that 
needs to be filled to reach Universal Access1 to treatment for people who are affected. 
                                                
1 The requirements for reaching Universal Access have changed due to changes in the assumption of the net 
survival of people living with HIV without receiving treatment; this is 11 years instead of previously 9 years 
for all countries except those where subtype E constitutes the majority of infections. As part of this assumption, 
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Universal Access is not the same as 100% coverage in treatment, as there will always be 
some people not wishing to seek treatment of various reasons.  
2.2 Resource mobilization  
The best available estimates of global needs for AIDS indicate that global resource 
requirements amount to a total of USD 15 billion in 2006, USD 18 billion in 2007 and USD 
22 billion in 2008 for prevention, treatment and care, support for orphans and vulnerable 
children (OVC), as well as programme and human resource costs (UNAIDS, 2005) (Table 
1).  
Table 1 AIDS Resource needs in US$ billions 
US$ billion 2006 2007 2008 Total for 
20062008 * 
Prevention 8.4  10.0  11.4  29.8 
Treatment and 
care 
3.0  4.0  5.3 12.3 
OVC 1.6 2.1  2.7 6.4 
Programme 
costs 
1.5  1.4  1.8  4.6 
Human 
resources 
0.4  0.6 0.9 1.9 
Total 14.9 18.1 22.1 55.1 
 
* The totals for 20062008 have been rounded to the first decimal place, with the result that there may be small 
differences with the figures for subtotals in the text because of rounding errors. 
 
The estimates for the AIDS resource needs are based on the High-Level Meeting on The 
Global Response to AIDS: Making the Money Work  The Three Ones in Action on March 
9th 2005 (UNAIDS, 2005). The figures have then been refined and updated on the basis of 
newly available information and input from the recently formed Resource Needs Steering 
Committee and the Resource Needs Technical Working Group2. Currently, the Resource 
Needs Technical Working Group is working on updated estimates, including new 
interventions like male circumcision. These are scheduled to be out by June 2007.   
                                                                                                                                                 
people living with HIV will become eligible for treatment an average of 3 years before they are expected to die 
from an AIDS related cause, instead of previously 2 years (Stover, 2007). 
2 These advisory groups were formed subsequent to March 9 2005, and are composed of international 
economists and AIDS experts from donor and developing countries, civil society, United Nations agencies and 
other international organizations. 
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Lately, there have been some concerns in the media that too much money has been spent on 
HIV and AIDS (England, 2007). Paul Delay and colleges argue that in fact the USD 15 
billions needed in 2006, only USD 9 billions were available for HIV and AIDS (Delay et al., 
2007). Furthermore, they claim that the bulk of the funding is additional to amounts spent 
on other aspects of health development, reflecting that money for HIV and AIDS are used 
to build up health infrastructure. They also stress the importance of that greater efforts are 
needed to make sure that those countries that are able to do so invest more of their own 
money in AIDS. 
2.3 Governmental effects  
Receiving substantial amounts of HIV/AIDS funding can also affect the macroeconomic 
stability of a country (Lewis, 2005). A large aid flow could potentially lead to appreciation 
of the exchange rate and an increased inflation rate. The absorptive capacity is generally low 
in low-income countries, and there is a problem that resources are diverted from other 
sectors (potential Dutch disease). A problem with receiving aid is that the government often 
does not have the saving/investment decision, since most aid comes with time limits and 
restriction on its use. These are negative short term effects on the economy. In the long term, 
macroeconomic literature suggests that if the aid is used effectively this effect can be 
reversed. Prolonging the life of the citizens increases the countrys human capital and hence 
its production capacity. However, aid flows are shown to be highly volatile (Bulir & 
Hamann, 2003), hence, dependency on aid flows is risky for the sustainability of the 
response to the HIV epidemic. If the governments are capable of taking on more of the 
responsibility themselves instead of relying on aid the planning of long term objectives will 
become easier, and thus problems of unpredictability and inconstancy often incurred with 
receiving aid can be avoided.   
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3. Data sources, data, and definitions 
In this section, the variables included in the analysis will be defined, as well as the 
conceptual framework giving the reasoning of the analysis performed in section 4.   
3.1 The dependent variable  domestic public expenditures on HIV and AIDS 
The definition of the variable 
The dependent variable, the domestic public expenditure related to HIV and AIDS, is 
defined as the amount of national funds (including reimbursable loans) spent by 
governments from domestic sources for HIV and AIDS. This includes expenditures on a 
regional and general level, as well as social schemes. The expenditures on HIV and AIDS do 
not include only health related issues, but also other issues as programme costs and advocacy 
in schools and workplaces. Significant spending has also been directed to strengthening of 
health infrastructure and capital, e.g. laboratory networks, universal precautions, blood bank 
safety and safe injections. 
The main spending categories are: 
1. Prevention  
2. Care and treatment  
3. Orphans and vulnerable children3 (OVC) 
4. Programme management and administration strengthening 
5. Incentives for human resources 
6. Social protection and social services (excluding OVC) 
7. Enabling environment and community development 
8. Research (excluding operations research included under programme management) 
 
Sources of information 
The primary database for the domestic public spending would be from the UNGASS country 
reports which 189 countries have committed themselves to deliver every two year. It 
addresses global, regional and country-level responses to prevent new HIV infections, 
                                                
3In the context of resource needs estimates and AIDS  Spending Assessments, vulnerable children are defined 
as those who have at least one parent who is alive but seriously ill (mainly because of HIV) and unable to take 
care of them.  
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expand health-care access and mitigate the epidemics impact.  At the United Nations 
General Assembly Special Session on HIV/AIDS (UNGASS) in June 2001, the Declaration 
of Commitment on HIV/AIDS was adopted by 189 Member States (UNAIDS, 2007). The 
Declaration of Commitment reflects global consensus on a comprehensive framework to 
achieve the Millennium Development Goal of halting and beginning to reverse the 
HIV/AIDS epidemic by 2015. The information is summarized in the UNGASS 2005 
Reporting (UNGASS, 2006), and the domestic public expenditures used to be reflected in 
first indicator (GE-01) among a series of core indicators developed to measure the progress 
in implementing the agreed-on commitments from the Declaration. After the revision on the 
indicators issued March 2007 (UNAIDS, 2007), this indicator will now consist of domestic 
expenditures by categories and financing source. The data collection frequency is annual and 
the National Aids Spending Assessment will be the primary tool of measurement. 
 
When the UNAIDS Progress Report on the Global Response to the HIV/AIDS Epidemic 
(UNAIDS, 2006) was published, all of the country progress reports were not yet returned 
and new arrivals will be used to fill in numbers if they are sufficiently explained. The 
country progress reports can also be handed in using the Country Response Information 
System (CRIS), which is a computerized and standardized complement to the UNGASS 
narrative report. Another source is the National Aids Spending Assessments (NASA). This is 
a fairly new initiative and not many reports are received yet. NASA is a country-based 
survey sent to governments, reporting on HIV/AIDS spending, which is not only related to 
the health sector. The NASA predecessor, National AIDS Account (NAA) is an important 
source for earlier years. The NAA tracks the total HIV/AIDS expenditures from all sources 
of finance, including public, private, households and external sources. This data is in the 
SIDALAC database which mostly includes Latin American countries. The fifth source for 
data is from the National Health Accounts which has a sub analysis for HIV/AIDS. The last 
source would be various financial economic reports with relevant data, to be specified later 
in the paper. The database for this work was retrieved using all the six sources of 
information. 
 
Limitations 
There are limitations to the data available. Good and accurate data has been available only in 
the last years. Reporting takes time and capacity, which the governments, especially in low-
income countries, lack. When countries reported public expenditures, it has not always been 
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clear what is meant. Instead of the actual amount spent, some reported commitments and 
some reported the amount budgeted, which can differ severely. In some cases, there was also 
a problem of what the number contained; public expenditures related to HIV/AIDS mixed 
together with aid, or they only included the HIV expenditures related to health, etc. This 
could be due to the survey form, or perhaps limited time to read the manual. However, the 
data chosen for this analysis was thoroughly screened, and many reports were rejected. All 
the data for this analysis was validated by the countries themselves. Many countries have not 
reported information on HIV expenditures at all, for the UNAIDS Progress Report on the 
Global Response to the HIV/AIDS Epidemic (UNAIDS, 2006). Only 40% of the countries 
that submitted reports supplied information related to national indicators, such as the GE-01 
indicator.  
 
Populating the dependent variable 
With 65 data points, 2004 is the most complete year, followed by 2003 and 2005. Thus, 
2004 was used for the further analysis. However, in some cases the adjacent years were used 
to populate horizontally using averages or linear interpolation and extrapolation according to 
certain criteria. 
 
The data was populated horizontally according to some conservative rules: only missing data 
for the year 2004 were filled in to increase the sample size for the cross sectional analysis. 
The missing data between years where observations are available were filled in; If there at 
least as many observations available as the number of missing data, the blanks were replaced 
by estimates using linear interpolation (n=4). When there were only two observations the 
average was used to fill in the gap (n=2). Extrapolations ahead were only done when having 
four observations or more. If there were observations for four years only one year ahead will 
be estimated (n=3). Two years ahead were estimated when having five or more consecutive 
years (n=2). There were no estimations more than two years ahead. The method used was 
linear extrapolation (least squares). Two missing data were replaced by average because the 
trend component was too large to use linear extrapolation, and three were replaced by the 
average of the observations for 2005 and 2006. 
 
In total, the year 2004 had 65 data points for public domestic expenditures originally, and 
after the estimation methods described above the sample size increased to 81 data points, and 
hence making it more robust. 
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3.2 The conceptual framework: theory and explanatory variables 
The aim of the empirical analysis is to explain what determines the domestic public 
expenditure on HIV and AIDS for a country. Another goal is to predict these expenditures in 
countries where data for this variable is lacking. Considering that expenditures on HIV and 
AIDS include prevention, treatment and care, different explanatory variables were included. 
Treatment is likely to be driven by the burden of the disease, while prevention expenditures 
would be depending on the HIV awareness in the country. In both cases, the budget 
constraint is limiting the spending possibilities, as well as other constraints the countries 
face.  
 
Through discussions with experts in UNAIDS, four different variables were identified and 
thought to be collectively exhaustive in describing what determines the HIV expenditures in 
a country: 
1. The amount of money available: The government expenditures on HIV and AIDS 
most likely depend strongly on their income. The income affects the level of 
spending because, obviously, the governments cannot spend more than they have, 
and often the income is not sufficient to cover the need in low- and middle income 
countries. 
2. The ability to spend the money available: Evidence from Sub-Saharan Africa 
suggests that even though they have sufficient funding, Sub-Saharan countries have 
difficulties in using the money available because of constraints on the absorptive 
capacity. One constraint could be that they do not have enough human resources 
(HR), another would be the lacking of infrastructure. Another measure that affects 
the ability to spend available money is governance and stability. The economic 
environment is crucial when it comes to ability of spending, as a country in conflict 
or post conflict situation, or with corruption problems is not as capable of spending 
the money to meet public needs like other countries with a different political reality. 
3. The burden of the disease: If a government allocates money to HIV and AIDS it is 
because people in the country are affected by HIV and AIDS. Countries with a high 
burden of the disease need more resources than countries with fewer HIV cases, and 
thus are prone to allocate more resources to HIV and AIDS. However, countries most 
strongly affected by HIV often are the countries with the least resources. 
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4. The willingness to spend the money available: Some governments might have the 
money to spend and the ability to spend the money on HIV and AIDS, but lack the 
political will or commitment. In Latin America there is a saying that demand drives 
the expenditures on care and treatment, but political will drives prevention 
expenditures.  
 
These four variables that, according to this simple theory, would explain HIV related 
expenditures are difficult, if not impossible to observe as such. We would therefore have to 
seek for observable variables carrying information on these four unobservable variables. 
 
Figure 1 The conceptual framework 
 
 
Figure 1 describes the relationship we assume between the four unobservable variables, to be 
considered as exogenous, and the HIV expenditures. The arrows indicate our belief that there 
is a uni-directional causality in that expenditures on prevention and treatment have no 
feedback on the need for the money. Neither do we intend to model that these 
expenditures in the current year may affect the burden of disease in later years. We make this 
simplification because we have one observation from each country only, and hence are 
forced to use a static model. The arrows between the four exogenous variables indicate that 
they are not unaffected by each other. The amount of money available is expected to affect 
the ability to spend money, since richer countries often have more human resources or less 
jY Money spent 
by governments 
on HIV and 
AIDS
*
2Z Amount of 
money available
*
3Z Commitment
/will to spend the 
money 
*
1Z Abilit
y to spend 
the money 
available  
*
4Z The 
burden of the 
disease 
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problems with for example corruption. The same goes for the inverse relationship; the better 
infrastructure and less corruption, the better environment for generating money. The amount 
of money available is also expected to affect willingness to spend money, since it is easier to 
commit to spending money, or express political will to spend money, if there is actual money 
to be spent. Willingness to spend money is expected to have an effect on the ability to spend 
money, since a committed government would build up the infrastructure needed to enable 
spending. Last, the arrow between the need and willingness to spend money suggests that the 
stronger the burden of disease, the more pressure on the government to pledge for spending 
money on HIV interventions. These relationships between the four exogenous variables are 
not, however, part of our formalized model.   
 
The four latent variables were assumed to have a linear relationship with the domestic public 
expenditures on HIV and AIDS. The relationship can be described by the following 
equation: 
 
(i) jjjjjj uZaZaZaZaaY +++++=
*
44
*
33
*
22
*
110  
 
Where Y is the domestic public expenditures on HIV and AIDS for country j and *ijZ  (I = 
1,2,3,4) are the four variables. The as are constants, which would be bigger the more 
important the variable is. As explained above, our theory suggests that the variables all have 
a positive relationship with the HIV expenditures, and thus conceptually the as are all 
positive. ju  is the normal distributed error term, capturing all the factors that cause domestic 
public expenditures to vary not captured elsewhere in the model. This equation rests on the 
assumption that the *ijZ  are exogenous, that there is no feedback from the jY  to 
*
ijZ (indicated 
by the arrows in figure 1 only pointing towards the money spent by governments on HIV 
and AIDS, and not backwards), which gives ( ) 0,cov * =jij uZ  for all i and j. 
 
The problem is, however, that since the *ijZ  are non-observable, or latent variables, the as 
remain unidentified and the domestic public expenditures on HIV and AIDS cannot be 
predicted from equation (i). Latent variables, as opposed to observable variables, are 
variables that are not directly observed but are rather inferred from other variables that are 
observed and directly measured, called proxies. For a variable to be a good proxy it must 
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have a close connection (or high correlation) with the inferred value. Thus, good proxies for 
*
4
*
1 ,..., jj ZZ  must be found for as many countries j as possible. Assuming that the proxies 
found only affect the according latent variable, thus that the latent variables are mutually 
exclusive, the relationships between the proxies and the latent primary explanatory variables 
could be modeled by the equations: 
 
(ii) ∑
=
++=
ik
k
ijkijikij eXZ
1
0
* αα , 
where i = 1, 2, 3, 4,  j is still the country number, and k indicates the number of the proxy X, 
aiming to explain the latent variable *ijZ . ikα  cannot be known or estimated since 
*
ijZ  is 
unobservable. ije  is the error term capturing effects of changes in 
*
ijZ  not explained by the 
Xs.  
 
Combining (i) and (ii) to eliminate *4
*
1 ,..., jj ZZ , gives an equation between observable 
variables: 
(iii) jk
estimated
k
k
kjk
estimated
k
k
k
ercept
j XaXaaaaY 4
1
441
1
11
int
4041010
41
......
4342143421
44 3444 21 ∑∑
==
++++++= αααα       
444 3444 21
jverror
jjj eaeau
=
++++ 4411 ... , 
 
where the coefficients 4,...,1 ikiiki aa αα  are the coefficients to be estimated in the multiple 
regression model. The intercept and the error term are now combinations of the intercepts 
and error terms in equations (i) and (ii). The number of observable regressors will be 
k1+k2+k3+k4. 
Some other assumptions: 
1.  ju  is uncorrelated with ),...,( 41 jj ee  
2. ju and ),...,( 41 jj ee are uncorrelated with all kijX  
These assumptions make the new error term jv  uncorrelated with the all kijX , so again no 
feedback is assumed from the Ys to the Xs. 
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Selection of proxies  further discussion 
Figure 2 visualizes the extended conceptual framework when all the proxies (Xs) are 
included. The availability of the different proxy variables, their possible overlapping, and 
how to proceed with distinguishing between the indispensable proxies and those which can 
be represented by others, will be discussed during the empirical analysis in order to find the 
variables that should be tested when searching for the final model.   
 
Figure 2 The conceptual framework with proxy variables indicated 
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In principle, all Zs could depend on all Xs, but in this model the proxies are assumed to 
affect only one X each. The exception is the share of people in urgent need of ART that 
receive ART treatment, which could carry information on the ability to spend money and the 
willingness to spend money.  
The explanation of the choice of proxies is divided in sections of the four latent variables 
they are aiming to explain:  
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The burden of the disease: A proxy for the burden of the disease in the country should be 
included in the model. Information suggests that when prioritizing government funds, 
children have the highest priority, followed by women, and last men. Public funds are more 
easily raised to save children, which would suggest that prevalence among youth could be a 
determinant for the public expenditure on HIV and AIDS. However, governments could be 
reluctant to spend money on HIV and AIDS on adults, but when the urgent need is great they 
face no other choice. When a large ratio of the working people is affected by HIV, spending 
money on HIV has higher priority so people in urgent need of ART treatment should be 
tested as a determinant for HIV expenditures. 
 
Amount of money available for spending: The gross domestic product (GDP) or gross 
national income (GNI) of a country is often used to indicate a countrys income; it is easily 
obtained and measures how much the economy actually produces within a country. In an 
article by Musgrove, Zeramdini and Carrin (2002), the GDP level has shown to be associated 
with total health spending. The analysis included both high and low income countries, and 
one result was that total health spending rouse from around 23% of GDP at low incomes to 
89% at high incomes (Musgrove et al., 2002:134), and that health takes an increasing share 
of total public expenditure as income rises. Since a part of the public HIV spending is 
included in the public health spending, GDP is suspected to be correlated with domestic 
public expenditures on HIV and AIDS. The choice has to be made whether the GDP should 
be calculated using purchase power parities (PPP), international dollars or average exchange 
rate. Converting to PPP would give a better picture of the countrys purchase power of the 
available HIV and AIDS expenditures. For instance, an equal amount of money would pay 
for more physicians in one country than in another. If, however, the GDP is converted, the 
domestic public expenditures should be converted in the same way.  
 
When it comes to representing the money a government has available for spending, GDP 
alone might not be the solution. A country with a large budget deficit can at the same time 
have a high GDP. Taxation is one source of income for the governments, and the percentage 
of government income which comes from tax could improve the measurement of their actual 
income. However, since tax is a less important source of revenue in low- and middle income 
countries than in high-income countries, perhaps it is not that relevant in our model. 
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The amount of aid given as budget support would increase the money available in the 
country. Budget support was chosen to capture the effect of aid flows increasing the 
spending capacity of the government. While aid received by the country is often earmarked 
certain projects, budget support is given directly to governments and is undistinguishable 
from other sources of revenue and should therefore be included in the analysis. 
  
The external debt service information we tried to track down was on how much of the money 
available for the government went to debt. Many countries claim having problems since a 
substantial part of the revenues goes to paying debt, and the variable should therefore be 
relative to the income of the country. The variable found was debt service as percentage of 
GNI. The reason for using debt service was that poor countries had a large percentage of 
total debt of the GNI, but smaller debt service. That could be interpreted as poor countries 
with a large debt, but not paying off a large amount each year. For this analysis, it is better to 
use the percentage they actually pay, since the goal is to examine how the money available 
each year is affected by having to pay debt. A country using 70 percent of the GNI to pay 
back debt would be assumed to have less money to spend on a response to HIV. 
 
Ability to spend money: Since a countrys absorptive capacity is difficult to measure, and 
currently there are no existing indexes available, variables carrying information on the level 
of absorptive capacity in the country should be included in the model to account for this 
effect. The number of physicians per capita gives an image of the human resources in the 
country. Since it is not necessary to be a trained physician to give antiretroviral treatment or 
to perform other services needed, the number of health workers or nurses per capita could be 
a better measurement. 
 
Governance could be another issue impeding the ability to spend money. If the country is 
politically unstable it is difficult to deliver services, and infrastructure may break down. A 
WHO report on the African region for instance states: Social and political instability, 
including war and mass population displacement in several countries, have disrupted health 
services (WHO, 2002:65). The more politically unstable a country is, the more unable the 
country is to spend money on HIV and AIDS; one reason being that unstable countries in 
conflict have high military expenditures. This indicator is suspected to be correlated with 
GDP, since poor countries are often more politically instable. There is also evidence that 
HIV prevalence is associated with poor governance (Menon-Johansson, 2005). 
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Another variable that affects the ability to spend available money is the level of corruption. 
Money intended to go to HIV and AIDS projects could go elsewhere due to corruption. 
Tayler and Dickinson (2005:10) identify treatment programmes as the most vulnerable, since 
Money for high-value drugs can be embezzled at any number of points in the procurement 
and distribution chain. This could give an indication on how the government policy acts in 
the country and it also provides a hint of the absorptive capacity. 
 
Commitment and willingness to spend money: The level of commitment of a country aims 
to measure how much a government is concerned about its citizens; if it usually spends a lot 
on social security relative to other expenditures, it could be more prone to spend money on 
HIV and AIDS. However, no measure of social security per se was found. Since education is 
a large share of social spending, the literacy rate was used as a proxy for how much 
governments spend on education, since a high literacy rate would imply a good education 
system and thus a higher level of spending on education. 
 
The size of the public health expenditures is also an indicator of how much the government 
commits to paying for its citizens. A government willing to allocate money to the health 
sector would be expected to be more prone to spending money on HIV and AIDS than 
governments that do not. However, the care and treatment part of HIV and AIDS spending 
would be included in the public health expenditures. Since antiretroviral treatment is 
expensive, this is often a great share of the total spending for HIV and AIDS. One would 
also believe that total health expenditures are strongly correlated with GDP per capita. 
 
The share of out-of-pocket expenditures (OOPE) on health could give indicate how 
committed the government is. Higher public expenditures have been identified as important 
financing mechanism to bring down the share of out-of-pocket expenditures (Xu et al. 2003), 
so a higher share of out-of-pocket expenditures should mean lower public domestic 
expenditures. An inverse of the OOPE share could then be a predictor for how much the 
government spend in a country on HIV and AIDS. The OOPE for health is not the same as 
for HIV and AIDS, but currently good estimates are not available for HIV and AIDS. Most 
likely, OOPE for HIV and AIDS are higher than for health in general because catastrophic 
diseases are usually less covered by insurance, particularly by private insurance. Since the 
estimations for OOPE on health are survey based and most likely not as accurate for all 
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countries, using the domestic public health expenditures as share of total health expenditures 
is better. Instead of using domestic public health expenditures per capita in the model, the 
share of the total is used. Using the share of the domestic public spending and not the 
amount the model captures whether the burden on people is relatively high or low, and thus 
avoiding the use of OOPE share. 
 
However, countries could spend a lot on education and other social services, but they could 
be reluctant to spend money on HIV and AIDS. The reasons could be stigma or ignorance 
about the epidemic, or perhaps that HIV and AIDS is not prioritized. Thus, the level of 
advocacy in the country could serve as an indicator of how much awareness they have. In 
this respect, it might be useful to look at how many NGOs there are in the country. NGOs do 
lobbying to make governments increase funding for, and prioritize HIV and AIDS. They also 
raise awareness about HIV and AIDS, escalating pressure from the people to act on giving a 
response to the epidemic.  
 
The government spending on HIV and AIDS is also affected by how much external aid the 
country receives. External aid could be a disincentive in the way that the country use less 
money from the government budget, since funding is received from elsewhere. When 
governments know funding would be high for HIV and AIDS, they are likely to prioritize 
other matters. Official Development Assistance (ODA) could be measured as a share of 
public health expenditures, because if some countries receive as much ODA for AIDS as 
their total health budget, they might think that AIDS should not be prioritized, but rather 
divert funding towards other issues. 
 
However, International funding channels like the Global Fund to Fight AIDS Tuberculosis 
and Malaria (GFATM) emphasize that their funds should be complementary and additive in 
the way that they should not replace existing national and international resources (Global 
Fund, 2003). The Global Fund also encourages political commitment concepts, like per 
capita health expenditure, and existence of supportive national policies and multiyear 
strategic plans. Hence, countries might make an effort to show political will and government 
spending to attract donors. Moreover, a high level of external aid could also mean that the 
awareness of HIV is elevated, and that HIV spending is put in focus and prioritized. This 
would suggest that the negative effect could be minor, or in fact this effect might even be 
positive.  
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In conclusion, a priori, it is difficult to say if the effect of external aid will be positive or 
negative, but one would think that the first argument has a greater impact on the decision 
makers; i.e. the government, resulting in that the expected effect of high external aid would 
be negative.  
 
The internal dynamics 
Figure 3 below captures the internal dynamics in the model as discussed briefly above. The 
arrows represent supposed time lags which are not included in our static model. Enabling 
factors includes the economic, demographic and other macro development indicators giving 
information on how able the country is in spending money on HIV and AIDS. Allegiance 
factors give an indication of how much the country invests in its citizens, or how devoted it 
is in fighting HIV. The arrows between them go both ways: the country supports its citizens 
more when the government has more resources, and the more the country has an obligation 
to its citizens, the more they spend of their resources. Requirement factors are the 
epidemiological ones indicating the actual need in the country for HIV and AIDS spending. 
The arrows are going both ways in this case as well. The need is affected by how large 
resources the country has and through the allegiance factors how much it spends, because the 
more it spends, the more people are treated and the more people are prevented from getting 
HIV. The effect is also reversed since countries often spend more on HIV and AIDS if the 
burden of disease is high (and they are able to). Finally, press factors are indicators that 
could affect the allegiance or commitment the country has for the people affected by HIV. 
The NGOs in the country are raising awareness about HIV and AIDS, creating an incentive 
for the government to spend more money on HIV and AIDS. External aid, however, could be 
a disincentive to use money, since the government is not the sole provider of the money and 
they could delegate the money to other budget posts. The aid effect can be both negative and 
positive because of the previously discussed additive principle of the Global Fund. Thus one 
cannot be completely sure of the sign of this parameter. 
 
Figure 3 Internal dynamics between predictors 
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3.3 The definition of the proxy variables 
The explanatory variables stated in the conceptual framework were not all available, and for 
those that were, the reliability of the information was considered when choosing explanatory 
variables. The variables were not adjusted for purchase power parities (PPP) because the 
domestic public expenditures are not adjusted for PPPs. This conversion should be made in 
order to compare the countries expenditures, but for purpose of this analysis the data was 
not converted. 
 
All variables are for the year 2004 if not stated otherwise. This choice was motivated partly 
by how they are thought to affect decisions, and partly by their availability. When the data 
was scarce, the latest year available was used. Table A1 in the Annex includes an overview 
of how observations of the explanatory variables were retrieved. For example, the Tax 
Revenue variable had 50 data points for 2004, but 76 data points when including the latest 
year available. Whenever an observation was reported as a range, the midpoint was used (for 
example >0.1 was replaced by 0.05). 
Requirement 
factors 
 
HIV Prevalence 
Number of 
people in need 
of ART 
Number of 
people in urgent 
need of ART 
Number of 
people 
receiving ART 
Population in 
the country 
 
Enabling 
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GDP 
GNI 
Income from 
Taxation 
Budget support
Debt service 
Political 
Stability 
Corruption 
Index 
Health -
Infrastructure 
Physicians per 
capita 
Health workers 
per capita 
 
Allegiance 
factors 
 
HDI 
Literacy 
Public     
expenditures on 
health 
Share of OOPE
Number of 
times AIDS is 
mentioned in 
public speeches
Press factors 
 
ODA as % of 
government health 
budget 
Number of NGOs in 
the country
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The proxies for *1Z : the ability to spend the money available 
Health infrastructure 
• Number of hospital beds (per 10 000 inhabitants) was retrieved from the WHO database 
of Core Health Indicators. Hospital beds include in-patient and maternity beds. Maternity 
beds are included while cots and delivery beds are excluded. 41 data points were 
available for 2004, and 91 when the latest years available were used. 
• Nurses (density per 1 000 inhabitants) was retrieved from WHO database of Core Health 
Indicators. Nurses include professional nurses, auxiliary nurses, enrolled nurses and 
other nurses, such as dental nurses and primary care nurses.54 data points were available 
for 2004, and 136 when the latest years available were used. 
• Physicians (density per 1 000 inhabitants) was retrieved from WHO database of Core 
Health Indicators. Physicians include generalists and specialists. 52 data points were 
available for 2004 and 137 when the latest years available were used. 
Governance 
• Political stability is one of the World Banks six dimensions of governance, the others 
being voice and accountability; government effectiveness; regulatory quality; rule of law; 
and control of corruption. Initiated in the late 1990s, its six dimensions are based on a 
longstanding research program of the World Bank Institute and the Research Department 
of the World Bank (World Bank, 2006). The aggregate indicator is constructed using an 
unobserved components methodology. The indicators are measured on a scale ranging 
from about -2.5 to 2.5, with higher values corresponding to better governance outcomes. 
The political stability was chosen since the dimensions of governance are highly 
collinear; around 0.8 in this sample, and since political stability was the one most 
correlated with the dependent variable (table A2). In the final model all the World 
Banks variables of governance will be tested for significance. The political stability 
indicator reflects the statistical compilation of responses on the quality of governance 
(How does risk of political violence influence government?). It gives the perceptions of 
the likelihood that the government in power will be destabilized or overthrown by 
possibly unconstitutional and/or violent means, including domestic violence and 
terrorism (Kaufmann et al., 2003). The indicator is based on 31 data sources produced by 
25 different organizations worldwide, e.g. African and Asian Development Bank, the 
Economist Intelligent Unit, Business Environment Risk Intelligence and the World 
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Economic Forum. The indicator contained negative values, thus the range of the 
distribution was moved from (-3.055, 1.448) to (0, 4.503) to ease the interpretation of the 
regression. 
• The Corruption Perception Index  The Corruption Perception Index by Transparency 
International (Transparency International, 2004) gives a measurement of the degree to 
which corruption is perceived to exist among public officials and politicians. The TI 
Corruption Perceptions Index (CPI) ranks more than 150 countries by their perceived 
levels of corruption, as determined by expert assessments and opinion surveys. The index 
might come under allegiance as being very subjective, as it is survey based and it reflects 
the views of businesspeople and analysts from around the world, including experts who 
are resident in the countries evaluated, but it is the most suited measure of corruption that 
can be used for empirical studies. 
 
The proxies for *2Z : the amount of money available 
• Gross Domestic Product (GDP) was obtained from the World Development Indicators 
(World Bank database). It measures how much an economy actually produces within a 
country. The limitations of to this measure are that developing countries often have a 
large informal sector, with transactions not being registered directly as output in official 
statistics. World Bank, data on population for each country was used to convert GDP and 
the domestic public expenditure on HIV and AIDS to per capita values. 
• Gross National Income (GNI) was retrieved from the World Banks World Development 
Indicator database. GNI measures the total value of goods and services produced within a 
country together with its net receipts for primary income received from other countries. 
GNI measures the countries claims on output rather than actual output as GDP does.  
• Definition: GNI (formerly GNP) is the sum of value added by all resident producers plus 
any product taxes (less subsidies) not included in the valuation of output plus net receipts 
of primary income (compensation of employees and property income) from abroad. Data 
are in current U.S. dollars. Source: World Bank national accounts data, and OECD 
National Accounts data files. Data from the World Bank on population was used to 
convert the figures to per capita values.  
• Debt service as percentage of GNI: The variable was retrieved online from the World 
Development Indicators database. Total debt service is defined as the sum of principal 
repayments and interest actually paid in foreign currency, goods, or services on long-
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term debt, interest paid on short-term debt and repayments (repurchases and charges) to 
the IMF. The GNI denominator is a three-year average.  
• Tax revenue as percentage of GDP was retrieved from the World Banks World 
Development Indicators database. According to the information reported, tax revenue 
refers to compulsory transfers to the central government for public purposes. Certain 
compulsory transfers such as fines, penalties, and most social security contributions are 
excluded. Refunds and corrections of erroneously collected tax revenue are treated as 
negative revenue.  
• Budget support in 2004 (2004 in current US dollars) was retrieved from the Organization 
for Economic Co-operation and Development (OECD), Creditor Reporting System 
(CRS). Budget support is money given as Official Development Assistance, none 
earmarked directly to the national treasury, hence undistinguishable from other country 
revenue. 
 
The proxies for 
*
3Z : the willingness to spend the money available 
Commitment 
• The variable on total domestic expenditures on health is a per capita measurement on 
domestic health expenditures for low- and middle-income countries, taken from the 
WHO database of Core Health Indicators. They are not necessarily the official statistics 
of Member States, which may use alternative methods. To date, only data from 2003 is 
available, thus the health expenditures converted by an average exchange rate was used 
to make them more comparable with the expenditure on HIV and AIDS.  
• Literacy rate, as it is measured by the UN, gives the percentage of the population 
between 15 and 49 years old which are able to read.  
• Government expenditures on health at average exchange rate (US$) as % of total health 
expenditures is measured as general government expenditure on health as percentage of 
total expenditure on health was retrieved from the WHO database of Core Health 
Indicators. The definition of general government expenditures on health (Public Health 
Expenditure) is the sum of outlays on health paid for by taxes, social security 
contributions and external resources (without double-counting the government transfers 
to social security and extra-budgetary funds). Total health expenditure is by definition 
the sum of Public Health Expenditure (PHE) and Private Health Expenditure (PvtHE). In 
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one case, the reported figure was below 1 for both government expenditures on health 
per capita and total health expenditures per capita; the midpoint 0.5 was then used. 
• Official Development Assistance (ODA) Commitments in 2004 (2004 in constant 
dollars) divided by domestic public health expenditures. The ODA statistics were 
retrieved from the Organization for Economic Cooperation and Development (OECD), 
Creditor Reporting System (CRS). Commitments were chosen over disbursements since 
this is known by the government at the beginning of the year, when they budget how 
much they should spend on HIV and AIDS, whereas the actual disbursed amount is not 
known until the end of the year. When no figure was reported, zero was used (n=35), 
assuming the country did not receive ODA if no commitments were reported. Three data 
points were lost due to lack of information on health expenditures. To include another 
variation of this variable, the ODA Commitments in 2004 (2004 in constant USD) was 
also divided by the number of people living with HIV. 
• People with advanced HIV infection receiving antiretroviral (ARV) combination therapy 
(%) was retrieved from the WHO database of Core Health Indicators. The definition is 
the percentage of people with advanced HIV infection receiving ARV therapy according 
to nationally approved treatment protocol (or WHO/Joint UN Programme on HIV and 
AIDS standards) among the estimated number of people with advanced HIV infection. 
When the number was stated as <50, the rule of using the midpoint, 25, was applied (ten 
cases). This data was recently published and is only available for the year 2005, but there 
is no reason to believe that drastic changes happened in one year. However, the 
endogeneity problem might be greater considering the year of the HIV expenditures is 
2004, and the data on coverage for ART are 2005.  
Advocacy 
None of the variables for advocacy were found for 2004, and the decision was made not to 
use observations from later years since changes happen fast in this area.  
The proxies for *4Z :the burden of the disease 
Retrieved from the UNAIDS internal database, the following proxies for the burden of the 
disease are considered: 
• Estimated number of people living with HIV, children (0-14) 
• Estimated number of people living with HIV, adult and children 
• Estimated number of people living with HIV, adults (15+) 
• Estimated HIV prevalence, children (0-14) 
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• Number of people with advanced HIV infection (urgent need) 
• HIV prevalence - The prevalence is a UNAIDS measurement giving the percentage of 
the adult population (15-49 years) having the HIV virus. For Serbia, data on the 
prevalence for 2004 was lacking and the average prevalence between 2003 and 2005 was 
applied.  
Table 2 present the summary statistics of all the proxy variables. 
 
Table 2 descriptive statistics for the proxy variables 
     ---------- Quantiles ----------  
 n Mean Std.Dev. Min 0.25 Median 0.75 Max 
GDP per capita 131 2553 2682 91 481 1294 3794 10794 
Budget support per capita 138 6.9 48.5 0.0 0.0 0.0 2.4 568.1 
Total debt service (% of GNI) 124 62.5 35.9 1.0 31.5 62.5 93.5 124.0 
Tax revenue (% of GDP) 76 16.6 8.3 2.0 11.4 15.3 21.0 54.4 
Number of hospital beds (per 10 
000 population) 93 34.2 27.8 1.5 12.0 25.0 53.0 132.0 
Nurses (density per 1 000 
population) 136 2.5 2.5 0.1 0.6 1.6 3.8 11.6 
Physicians (density per 1 000 
population) 137 1.2 1.3 0.0 0.2 0.6 1.9 5.9 
Literacy rate 138 20.1 23.9 1.0 1.0 4.5 39.0 81.2 
Political stability 137 -0.4 0.9 -3.1 -1.0 -0.3 0.2 1.5 
Corruption Index 108 3.2 1.2 1.5 2.3 2.8 3.8 7.4 
Government expenditure on 
health at average exchange rate 
(US$) as % of total health 
expenditures 
136 0.5 0.2 0.2 0.4 0.5 0.7 0.9 
ODA Commitments for HIV and 
AIDS in 2004 (2004 in constant 
dollars) as a ratio of domestic 
public health expenditures 
135 0.2 0.4 0.0 0.0 0.0 0.1 2.7 
ODA Commitments for HIV and 
AIDS in 2004 (2004 in constant 
dollars) as a ratio of people living 
with HIV 
120 753 3594 0.0 1.5 37.1 170 29744 
People with advanced HIV 
infection receiving antiretroviral 
(ARV) combination therapy (%) 
122 28.2 25.3 0.0 7.0 24.5 39.0 100.0 
Estimated number of people 
living with HIV, children (0-14) 115 18841 43147 0.0 63 1374 13720 220000
Estimated HIV prevalence, 
children (0-14)  113 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Estimated number of people 
living with HIV, adult and children 127 280000 770000 0.0 4404 30932 170000
550000
0 
Estimated number of people 
living with HIV, adults (15+) 126 260000 740000 0.0 4383 31284 160000
540000
0 
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HIV prevalence, adult (14-49) 127 2.7 5.6 0.0 0.1 0.7 2.3 33.1 
number of people in need of ART 113 55450 140000 1.0 1113 8624 37352 960000
 
3.4 Design 
The analysis is formally a cross sectional analysis for the year 2004 with 81 low- and middle 
income countries (ranked according to the World Bank Atlas method4) for which 
information on domestic public expenditures is recorded. Upper middle-income countries are 
also included; this increases the sample size and ensures more accuracy in estimation by 
giving a wider spread of the data.  
 
A cross-section analysis will be used because it is difficult to do a panel data analysis since 
the range in years is limited. We only have reliable information for the past few years 
because of the scarce availability of data, due to lack of registration of strategic information. 
This implies that time-serial information will not be captured by the data set. For the present, 
we do not have enough data available for conducting a reliable panel data study. 
 
Various variables will be tested to identify drivers for HIV and AIDS spending. An Ordinary 
Least Squares multiple regression model will be used to identify the final model from which 
we can predict domestic public expenditures related to HIV and AIDS for any given country. 
                                                
4Economies are divided into groups according to 2005 GNI per capita, calculated using the 
World Bank Atlas method. The groups are: low income, $875 or less; lower middle income, 
$876 - $3,465; upper middle income, $3,466 -$10,725; and high income, $10,726 or more. 
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4. Analysis 
The possible explanatory variables were collected, each considered a candidate for being an 
explanatory variable, and the dependent variable was analyzed to see their distribution, 
check for outliers and data entry errors, and look at the association of each variable with the 
domestic public expenditures for HIV and AIDS. Necessary transformations and tests were 
conducted to perform the analysis.  
 
A bivariate analysis was performed initially to determine which explanatory variables were 
to be included as candidates for the multiple regression model. The variables were 
considered candidates if the p-value of the simple regression was 20% or below, or if the 
variable was considered important enough from the conceptual framework perspective. 
These variables will be included in the model building, and categorical variables will be 
tested, such as regions, since we expect different regions to have a different spending 
pattern. 
 
When the final model was identified, diagnostics were computed to check the underlying 
assumptions. Unusual and influential observations were identified, and the assumption that 
the errors, and hence the dependent variable y conditional on the explanatory variables, are 
normally distributed, was tested for. Tests for heteroscedasticity of the residuals and 
multicollinearity between the explanatory variables were performed. The models 
specifications, e.g. omitted variable bias or the linearity assumption, were also tested. All of 
the tests support that the assumptions of the model hold. 
4.1 Univariate and bivariate analysis of the variables 
The dependent variable was transformed; the estimation of the regression coefficients do not 
require normally distributed residuals, but the residuals need to be normally distributed for 
the t-tests to be valid. A common cause of non-normally distributed residuals is non-
normally distributed outcome and/or predictor variables. The summary statistics shows that 
our dependent variable, namely the public domestic expenditures on HIV and AIDS is not 
normally distributed marginally. The mean exceeded than the median (table 3), which 
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indicates a positive skewness. The kurtosis was much greater than 3 which is the kurtosis of 
a normal (Gaussian) distribution, which indicates that the distribution has heavier tails. 
 
Table 3 Descriptive statistics for the domestic public expenditures per capita, 2004 
           domestic public expenditures per capita, 2004 
      Percentiles      Smallest 
 1%     .0017179       .0017179 
 5%     .0098273       .0030837 
10%     .0323192       .0043663       Obs                  81 
25%     .1039845       .0072835        
 
50%     .4153908                      Mean           2.403252 
                        Largest       Std. Dev.      10.66607 
75%     1.565415       4.786399 
90%     3.851129       7.776968       Variance       113.7651 
95%     4.524433       17.02529       Skewness        8.25474 
99%     94.98671       94.98671       Kurtosis       71.89583 
 
Transforming the dependent variable is useful in order to reduce or remove the 
heteroscedasticity of the residuals. In order to reduce a positive skewness, transforming the 
variable by e.g. the square root, the logarithm, the inverse are common methods. Testing this 
using Stata shows that the method giving the best approximation to the normal distribution is 
to transform the variable with the natural logarithm:  
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Figure 4 Distribution of the domestic public expenditures related to HIV and AIDS compared to the 
normal distribution after transformation by selected methods. 
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Transforming the dependent variable logarithmically significantly reduces the skewness, but 
the distribution now has a slight negative skewness (table 4). The kurtosis is now closer to 
three. 
 
Table 4 Descriptive statistics for the dependent variable, the logarithm of the domestic public 
expenditures per capita, 2004 
  Logarithm of the domestic public expenditures per capita, 2004 
      Percentiles      Smallest 
 1%     -6.36666       -6.36666 
 5%    -4.622586      -5.781615 
10%    -3.432093       -5.43385       Obs                  81 
25%    -2.263513       -4.92215        
 
50%    -.8785356                      Mean          -1.030097 
                        Largest       Std. Dev.       2.01471 
75%     .4481509       1.565778 
90%     1.348366       2.051167       Variance       4.059056 
95%     1.509492         2.8347       Skewness      -.2677454 
99%     4.553737       4.553737       Kurtosis       3.220231 
 
A simple linear regression was performed for each independent variable and the domestic 
public expenditure per capita to determine which explanatory variables are to be included in 
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the final multiple regression analysis. For an explanatory variable to be considered a 
candidate for the multiple regression the p-value should be less than 20%. However, as 
stated above, the variable not satisfying this requirement might still be included in further 
analysis if it is considered important conceptually. 
 
Descriptive statistics and associations 
In the further analysis, GDP per capita was used instead of GNI per capita since the 
correlation was slightly better (table 5). 
Table 5 Correlation matrix shows higher correlation between HIV expenditures and GDP per capita 
than for GNI per capita, both with and without logarithmic transformation 
  lndomex domexcap GDP/cap GNI/cap  
GDP/cap 0.5129 0.5875 1  
GNI/cap 0.5086 0.5847 0.9982 1 
 
The correlation for all variables5 with and without transformation of the dependent variable 
is found in table 6. The number of observations included in the correlations is in the row 
below.  
 
Table 6 Correlation coefficient between the domestic public expenditures on HIV and AIDS and its 
potential explanatory variables 
 lndomex domexcap 
GDP per capita 0.5237 0.2524 
 80 80 
Budget support per capita 0.1093 -0.0074 
 81 81 
Total debt service (% of GNI) 0.1781 -0.141 
 78 78 
Tax revenue (% of GDP) 0.1624 0.2676 
 46 46 
Number of hospital beds (per 10 
000 population) 
0.1919 0.1809 
 50 50 
Nurses (density per 1 000 
population) 
0.1588 0.0557 
 80 80 
Physicians (density per 1 000 
population) 
0.0875 -0.0499 
 81 81 
Literacy rate -0.0111 0.2309 
 81 81 
Political stability 0.5634 0.2579 
 80 80 
                                                
5 The cross correlation coefficients are in the annex, table A3  
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Corruption Index -0.0062 -0.0046 
 61 61 
Government expenditure on 
health at average exchange rate 
(US$) as % of total health 
expenditures 
0.3601 0.0927 
 81 81 
ODA Commitments for HIV and 
AIDS in 2004 (2004 in constant 
dollars) as a ratio of domestic 
public health expenditures 
-0.2609 -0.0528 
 81 81 
ODA Commitments for HIV and 
AIDS in 2004 (2004 in constant 
dollars) as a ratio of people living 
with HIV 
-0.2515 -0.0447 
 75 75 
People with advanced HIV 
infection receiving antiretroviral 
(ARV) combination therapy (%) 
0.5336 0.3356 
 74 74 
Estimated number of people living 
with HIV, children (0-14) 
0.0016 -0.0139 
 73 73 
Estimated HIV prevalence, 
children (0-14) 
0.2566 0.3109 
 73 73 
Estimated number of people living 
with HIV, adult and children 
0.0262 0.0095 
 76 76 
Estimated number of people living 
with HIV, adults (15+) 
0.032 0.0101 
 75 75 
HIV prevalence, adult (14-49) 0.3444 0.4468 
 76 76 
number of people in need of ART 0.0688 0.0134 
 73 73 
 
 
The correlation between ODA as percentage of government health expenditures of domestic 
public health expenditures and expenditures related to HIV and AIDS is in fact negative. 
That could support the suspicion that governments receiving a lot of aid for HIV and AIDS 
prioritize other budget posts. The scatter plot in figure 5 confirms that ODA as percentage of 
government health expenditures shows a tendency of a negative trend, but only after a 
certain threshold. When the ODA is under 60 % of the health expenditures, no pattern is 
observable (figure 6). When the ODA exceeds 60% of the health expenditures, there is an 
almost perfect linear decline in public expenditures for HIV and AIDS. The observations are 
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too scarce to affirm this tendency (n=5), this should be further  investigated when more data 
is available on this matter. 
 
Figure 5 The Official Development Assistance plotted against the domestic HIV expenditures  
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Figure 6 The share of Official Development Assistance plotted against the domestic HIV expenditures 
when the share is 60% or less 
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Debt service as percentage of GNI has a negative correlation with domestic public 
expenditures related to HIV and AIDS when the latter is untransformed. This supports our a 
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priori assumption that countries which use a greater share of the money available to pay back 
debt would use less on HIV and AIDS. However, with the logarithmic transformation of the 
dependent variable the correlation becomes positive. The scatter plot in figure 7 shows that 
Botswana is a prominent outlier; when this observation and the observation of Barbados are 
deleted there is no obvious pattern. 
Figure 7 Debt service as % of GNI plotted against HIV expenditures without transformation 
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Figure 8 Debt service as % of GNI plotted against the logarithm of HIV expenditures  
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After the variable for GDP per capita was logarithmically transformed, the scatter plot shows 
a clearly nonlinear relationship between domestic public expenditures on HIV and AIDS per 
capita and the GDP per capita (figure A1). The same is indicated by a test of linearity with 
the final model with no transformation of GDP (figure A2). The plots provide evidence of a 
concave relationship between GDP and HIV spending. A way to come around this is to 
introduce a variable of GDP squared, or simply to do a logarithmic conversion of the GDP, 
hence avoiding the decrease the degrees of freedom and easing the interpretation of the 
coefficient. The explanation is that HIV expenditures rise with rising GDP, but at a 
decreasing rate (figure A1). The logarithmic transformation of the variable GDP also 
changes the interpretation of the coefficient in the regression model. When we have log of 
GDP, it is interpretable as an X% change in GDP being associated with a Y% change in HIV 
expenditures, while for GDP it is a $X change in GDP being associated with a Y% change in 
HIV expenditures. 
 
Simple regression 
The criterion for the inclusion of the variables to be considered in the multiple regression 
was their significant t- statistic and thus a p-value of around 20% or less when doing a 
simple regression. If, however, the variable is considered important enough from the 
conceptual framework, it might still be included in further analysis even if it does not satisfy 
these statistical criteria. Twenty-one variables were tested. Table 7 provides the results from 
the simple regressions. 
Table 7 results from the simple regressions 
Proxy variables logarithm of domestic public expenditures on HIV 
and AIDS 
 coeff standard 
error 
t-
value
p-
value 
r-
square 
GDP 0.0004 0.0001 5.43 0.000 0.274 
Logarithm of GDP 0.9712 0.1611 6.03 0.000 0.318 
Budget support per capita 0.0035 0.0036 0.98 0.332 0.012 
Total debt service (% of GNI) 0.0096 0.0061 1.58 0.119 0.032 
Tax revenue (% of GDP) 0.0350 0.0320 1.09 0.281 0.026 
Number of hospital beds (per 
10 000 inhabitants) 
0.0141 0.0104 1.35 0.182 0.037 
Nurses (density per 1 000 
inhabitants) 
0.1392 0.0980 1.42 0.160 0.025 
Physicians (density per 1 000 
inhabitants) 
0.1536 0.1968 0.78 0.437 0.008 
Literacy rate -0.0009 0.0093 -0.1 0.921 0.000 
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Political stability 1.3673 0.2270 6.02 0.000 0.318 
Corruption Index -0.0093 0.1943 -0.05 0.962 0.000 
Government expenditure on 
health at average exchange 
rate (US$) as % of total health 
expenditures 
3.8775 1.1301 3.43 0.001 0.130 
ODA Commitments for HIV 
and AIDS in 2004 (2004 in 
constant dollars) as a ratio of 
domestic public health 
expenditures 
-1.2514 0.5210 -2.4 0.019 0.068 
ODA Commitments for HIV 
and AIDS in 2004 (2004 in 
constant dollars) as a ratio of 
people living with HIV 
-0.0010 0.0004 -2.22 0.029 0.063 
People with advanced HIV 
infection receiving antiretroviral 
(ARV) combination therapy (%) 
0.0431 0.0080 5.35 0.000 0.285 
Estimated number of people 
living with HIV, children (0-14) 
0.0000 0.0000 0.01 0.990 0.000 
Estimated HIV prevalence, 
children (0-14) 
191.2753 85.4895 2.24 0.028 0.066 
Estimated number of people 
living with HIV, adult and 
children 
0.0000 0.0000 0.23 0.820 0.001 
Estimated number of people 
living with HIV, adults (15+) 
0.0000 0.0000 0.27 0.785 0.001 
HIV prevalence, adult (14-49) 0.1077 0.0341 3.16 0.002 0.119 
number of people in need of 
ART 
0.0000 0.0000 0.58 0.563 0.005 
 
The regression analysis gives a p-value below the predetermined critical value of 20% for 
the following variables: GDP per capita, total debt service (% of GNI), number of hospital 
beds (per 10 000 population), nurses (density per 1 000 population), political stability, 
government expenditure on health at average exchange rate (USD) as % of total health 
expenditures, ODA Commitments for HIV and AIDS as a ratio of domestic public health 
expenditures, ODA Commitments for HIV and AIDS as a ratio of people living with HIV 
and AIDS, people with advanced HIV infection receiving antiretroviral (ARV) combination 
therapy (%), and adult HIV prevalence (14-49 years). Budget support per capita, Tax 
Revenue (% of GDP), and the estimated HIV prevalence (0-14 years) was decided to be 
included in search for the final model, since they are important conceptually. However, Tax 
Revenue was only available for 46 of the countries where also information on HIV and 
AIDS expenditures is available. Since Stata automatically deletes the observations with any 
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explanatory variables missing, inclusion of the Tax Revenue would have deleted too many 
countries from the data set available for regression analysis. The literacy rate was also 
included in spite of its large p-value since it showed significance when the dependent 
variable was untransformed.  
 
In the search for the final model, ODA Commitments for HIV and AIDS is represented as a 
ratio of domestic public health expenditures instead of as a ratio of people living with HIV 
and AIDS since the correlation with HIV spending was slightly better (table 6). The five 
greatest values of the variable of ODA Commitments for HIV and AIDS in 2004 as a ratio of 
domestic public health expenditures were deleted since, as explained earlier, they were the 
ones creating the negative association with the dependent variable. 
 
The variable of people with advanced HIV infection receiving antiretroviral combination 
therapy (%) (ART coverage), showed a strong correlation with the HIV and AIDS 
expenditures (figure 9), and has a p-value of under 0.001, but this variable causes an 
endogeneity problem. There is a high risk of endogeneity since government expenditures for 
HIV and AIDS is probably increasing the coverage rate of ART. The problem is still present 
even though the model is only for the year 2004, since the variable of ART coverage is from 
2005. If this variable was to be included it should be using an instrumental variable, i.e. a 
variable highly correlated to ART, but with no endogeneity problems with the spending on 
AIDS.  The coverage of treatment of diabetes or a disease requiring high medical 
expenditures like cancer, or preferably another disease with stigma attached to it could be an 
instrument variable. This variable is not included in the search for the final model, but 
should be explored closer by instrumental variable techniques. 
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Figure 9 Antiretroviral treatment (ART) coverage plotted against HIV expenditures  
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Thus, in summary, ten explanatory variables were considered for inclusion in the final 
model: The logarithm of GDP per capita, total debt service (% of GNI), number of hospital 
beds (per 10 000 population), nurses (density per 1 000 population), political stability, 
government expenditure on health as % of total health expenditures, ODA Commitments for 
HIV and AIDS in 2004 as a ratio of domestic public health expenditures, adult HIV 
prevalence (14-49 years), budget support per capita, and the estimated HIV prevalence (0-14 
years) per capita. 
4.2 The regression model 
The multiple regression model is estimated by the Ordinary Least Squares (OLS) method. It 
analyzes what determines the level of domestic public expenditure, how a change in the 
explanatory variables, i.e. the GDP level, prevalence etc. would affect the level of public 
expenditure.  This is the model used to find the coefficients of equation (iii) from the 
conceptual framework in chapter 3.2, and thereby allowing us to estimate the domestic 
public expenditures on HIV and AIDS, predicting in particular for countries for which this 
variable is unobserved. The simplified representation of (iii) is thus: 
exy ii
k
i
i ++= ∑
=
ββ
1
0     
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The dependent variable iy  denotes the logarithm of the domestic public expenditures on 
HIV and AIDS per capita and 0β  is the constant term. The explanatory variables are denoted 
by kxx ,...,1 . A dummy variable to examine for regional patterns, taking the form of shifts in 
the constant term, will be introduced. The e is the error term; it represents all variations in 
the dependent variable not explained by the model. The coefficients iβ  are unknown 
parameters. The parameter measures the effect of a change in its explanatory variable ceteris 
paribus (all other variables constant) on the dependent variable. That is if for example 2β  
equals 5, a 1 unit increase in the variable 2x will increase the domestic public expenditure 
related to HIV and AIDS by 5 percent. 
 
Some assumptions of the random errors need to be fulfilled for the estimators to be Best 
Linear Unbiased Estimator (BLUE) according to Gauss-Markov theorem: 
1. The expectation of the error term is zero 
2. The variance of the error term is constant and they are uncorrelated 
3. Any pair of errors is uncorrelated 
4. The random errors are normally distributed 
5. The values of the explanatory variables are not random; there are no exact linear 
relationship between them and there are more observations than explanatory 
variables 
These assumptions are consistent with the ones made in chapter 3.2 when deriving equations 
(i)(iii). 
 
When we have non-experimental data, these assumptions might often not be fulfilled, and 
we might not have BLUE estimates, but they can still be consistent or unbiased.  
 
4.3 Searching for the optimal model 
The model was estimated doing forward regression, since Stata automatically deletes the 
observations with any missing variables. The forward regression was done adding one by 
one the variables with the highest correlations (see table A3), and the choice was made to 
eliminate those variables for which a t-test gave a high p-value when included in the model. 
Table A4 in the annex gives the forward regression with the significant variables. The 
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forward regression yielded a model with GDP per capita, budget support per capita, political 
stability, and HIV prevalence as explanatory variables (regressors). The correlation matrix of 
the variables included in the final model is given in table 8 with and without log-
transformation of the dependent variable. 
 
Table 8 Correlation between the variables included in the multiple regression model and their 
correlation with the unconverted domestic expenditures on HIV and AIDS, n=74  
 lndomex domexcap Political 
stability 
Logarithm 
of 
GDP/cap 
GDP 
per 
capita 
HIV 
prevalence, 
adult 
Budget 
support 
per capita 
lndomex  1       
domexcap 0.4444 1      
Political 
stability 
0.5586 0.2868 1     
Logarithm 
of GDP/cap 
0.5431 0.2377 0.4857 1    
GDP per 
capita 
0.5043 0.2699 0.5288 0.8665 1   
HIV 
prevalence, 
adult (14-
49) 
0.3446 0.4472 0.12 -0.0979 -0.0552 1  
Budget 
support per 
capita 
0.0441 -0.0814 0.0046 -0.2623 -0.2676 0.0249 1
 
Interestingly, political stability is the variable which is most strongly correlated with the 
public spending on HIV and AIDS, followed by GDP which was expected to have a high 
correlation (table 9). These two variables also have a high correlation, 0.49, posing a 
potential multicollinearity problem. However, how serious this will be depends on the 
sample size, and the diagnostic gave evidence that this was not a problem. Since political 
stability is survey based, there is no chance of GDP to be a component of the political 
stability indicator. The correlation of the two is probably present because poor countries are 
often among the most unstable. The correlation of the budget support is not very strong, and 
in fact negative when public spending is untransformed.  
The budget support per capita was retained, with a t-test yielding a p-value of 0.0526 (table 
9).  
 
                                                
6 We expected this variable to have a positive association with HIV and AIDS spending, thus it is not necessary 
to check both tails of the distribution. By default the t test probabilities are two sided, for one-side tests, the p-
values could actually be divided in half. 
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A mentioned in section 3.3, the political stability was chosen over six dimensions of 
governance by the World Bank. The reason was the six dimensions; voice and 
accountability; political stability; government effectiveness; regulatory quality; rule of law; 
and control of corruption, are highly collinear, and that the political stability had the highest 
correlation with the dependent variable. However, the five other dimensions of governance 
were added to the current model to perform a joint hypothesis test. The joint hypothesis tests 
were done with the subset of coefficients, which is usually useful when we have several 
conceptually related predictors as in this case. The result when testing by an F-test the joint 
hypothesis that all of the six governance indicators coefficients are equal zero gave rejection 
at a p-value of 0.0223. When we test the hypothesis that all governance indicators except the 
political stability are all equal zero at the same time, the p-value is 0.2246 (table A5), which 
means that we cannot reject this hypothesis. These test and the fact that the dimensions are 
highly correlated with each other, indicate that it is sufficient to include only one. Political 
stability is the one that are strongest correlated with domestic public expenditures for HIV 
and AIDS, and the only one that is statistically significant in the current model. Altogether, 
the choice of political stability as a measurement for governance is supported, and the model 
is not changed. 
 
The next step to identifying the optimal final model was to test for regional variations and 
interactions between the explanatory variables. The residuals of the model without dummies 
were examined to check for patterns where the model most wrongly predicts the 
expenditures7, and then dummies are introduced to see if the model can be improved. In the 
residual plot for the model without dummies, the residuals seemed symmetrically distributed 
around zero which is consistent with the normal errors assumption. However, listing the ten 
highest and lowest residuals and their regions indicated that a regional pattern is indeed 
present. Among the ten largest residuals, seven were for Sub-Saharan countries, and three for 
Latin America. According to the analysis of the residuals, the model explain the least the low 
income countries and the countries in Sub Saharan Africa and Latin America, giving reason 
to create a dummy variable for the two regions. Including the dummies for Latin America 
(reg4) and Sub Saharan Africa (reg8) increases the adjusted r-square and thus the 
explanatory power of the model, and the dummies are significant (table A8). The two 
dummies together gave the highest r-square, and it shows that Sub Saharan Africa and Latin 
                                                
7 Residual plots and tables are in the annex, figure A3, and table A6-A7  
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America spends more per capita than others with the same levels of GDP, budget support, 
political stability and prevalence. 
 
The interaction between variables was tested; two explanatory variables are said to interact if 
the effect of one explanatory variable on the response variable depends on the level of the 
second explanatory variable, i.e. the first derivatives are not constant. Sub Saharan Africa 
was suspected to behave differently, and the scatter plot of expenditure on HIV and AIDS 
versus GPD level showed a flatter slope than for other regions (figure A4). Thus, an 
interaction was tested between the level of GDP and the region (reg8gdp). The flatter slope 
indicates that for the same income increase, less of the money goes to expenditure on HIV 
and AIDS, However, the intercept dummy shows a higher level of spending on average for 
the region. The result is confirmed by the significance of the interaction variable. For low 
levels of GDP, Sub Saharan Africa spends more, but the slope is not as steep as for other 
regions so when GDP reaches higher levels, the spending is not that high. Table 9 shows the 
results from the models with and without dummies: 
 
Table 9 Regression statistics with and without dummy variables, coefficients with standard errors in the 
parenthesis.  
                      lndomex     lndomex    
 
Logarithm of GDP/cap    0.848***    1.256*** 
                       (0.173)     (0.244)    
 
Budget support per      0.052#      0.059*   
capita                 (0.027)     (0.024)    
 
HIV prevalence adult    0.111***    0.095**  
15-49 years            (0.026)     (0.029)    
 
Political stability     0.736**     0.587*   
                       (0.251)     (0.227)    
 
Sub-Saharan Africa         --       5.197*   
                                   (2.148)    
 
Latin America              --       1.301**  
                                   (0.407)    
 
reg8gdp                    --      -0.575#   
                                   (0.319)    
 
Intercept              -9.564***  -12.948*** 
                       (1.094)     (1.656)    
 
N                          74          74    
R2                      0.549       0.664    
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Adjusted R2             0.522       0.628    
*** p<0.001; ** p<0.01; * p<0.05; # p<0.1;  two tailed 
 
The latter model had a better adjusted r- square, and thus a better explanatory power, and 
seemed more plausible. Hence it was chosen as the preferred model. 
4.4 The final model 
The final model explains the domestic public expenditures for HIV and AIDS by means of 
four variables; GDP per capita, budget support per capita, political stability, and HIV 
prevalence.  
gdpreggdpregregdomex ln*8575.0ln256.18197.54301.1-12.948ln −+++=
   epolstabprevalencebudgetcap ++++ 587.0095.0059.0  
 
Since the model includes several dummies, it is easier to see its implication by displaying the 
equation for the three regions separated. 
For Sub-Saharan Africa the equation will be: 
epolstabprevbudgetcapgdpdomex +++++−= 587.0095.0059.0ln681.0751.7ln
 
For Latin America the equation will be: 
epolstabprevbudgetcapgdpdomex +++++−= 587.0095.0059.0ln256.1.647.11ln
 
For the rest, the equation is: 
epolstabprevbudgetcapgdpdomex +++++−= 587.0095.0059.0ln256.1.948.12ln
 
When the equations are displayed separately, the atypical pattern for Sub Saharan Africa is 
more apparent. GDP per capita is not driving expenditures as much as in other regions, in 
fact the effect is halved. An increase of 1% in the GDP per capita gives 1.26% increase in 
expenditures in other regions, but only 0.6% increase for Sub Saharan Africa. Initially this 
region has, however, higher expenditures per capita reflected by the higher constant. 
 
As the model is now, it includes the three conceptual elements; the amount of money to 
spend, the ability to spend the money, and the need for money. No variables representing the 
willingness to spend money were found, and where available, they should be included in the 
model. 
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The GDP per capita together with the budget support shows that the more money available, 
the more the government spends on HIV and AIDS (table 10 gives their mean values by 
region). When removing the budget support, the other coefficients stay more or less the 
same, so this proxy accounts for the fact that there are countries with a low GDP still being 
able to spend money because of the received funding.  
 
Table 10 Mean values by region for GDP and budget support per capita 
 Region GDP/cap 
(curUS$) 
Budget 
support 
per 
capita 
Caribbean CAR 5,043 7.51
East Asia EA 1,066 0.00
Eastern 
Europe and 
Central 
Asia 
EECA 2,869 1.19
Latin 
America 
LA 3,123 2.04
Middle East 
& North 
Africa 
MENA 3,353 0.64
Oceania OCE 3,148 113.62
South & 
South East 
Asia 
SEA 1,307 0.73
Sub-
Saharan 
Africa 
SSA 1,052 3.78
Western 
and Central 
Europe 
WCE 6,111 4.79
 Total 2,534 6.85
 
The ability to spend money is captured by the variable political stability. From the results in 
table 9 we see that a one unit increase in the political stability gives a 0.59% increase in the 
spending. The political stability reflects the statistical compilation of responses on the 
quality of governance, asking questions like How does risk of political violence influence 
government? It is confirmed that this variable is indeed of importance when it comes to 
expenditures on HIV and AIDS. Sub Saharan Africa has a lower political stability than the 
total mean, while Caribbean countries are much more politically stable than the average 
(table 11).  
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Table 11 Mean values by region for political stability 
Region Political 
Stability 
CAR 0.471 
EA 0.205 
EECA -0.350 
LA -0.313 
MENA -0.864 
OCE 0.363 
SEA -0.796 
SSA -0.581 
WCE -0.036 
Total -0.386 
 
Prevalence is indicating the burden of the disease in the country. Table 12 shows clearly that 
Sub-Saharan Africa has a higher prevalence than any of the other regions.  
 
Table 12 Mean values by region for HIV prevalence among adults (15 to 49 years) 
Region HIV 
prevalence
CAR 1.661
EA 0.033
EECA 0.364
LA 0.649
MENA 0.201
OCE 0.900
SEA 0.387
SSA 6.915
WCE 0.070
Total 2.679
 
Per capita values are used to adjust for the size of the population; Mexico spends about 185 
million dollars on HIV and AIDS which is a lot more than El Salvadors 23 millions, but 
adjusted for population size El Salvador outranks Mexico by spending almost one and a half 
dollar more per capita (3,5 USD/cap compared to 1.8). 
 
Table 13 Mean values for domestic public expenditures on HIV and AIDS for the 81 observations 
Region DomEx/cap, DomEx04 
CAR 4.418 2 402 797
EA 0.076 97 991 976
EECA 0.382 10 107 024
LA 1.799 77 712 159
MENA 0.124 3 946 111
OCE 0.920 78 821
SEA 0.133 15 731 257
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SSA 4.149 23 453 889
WCE 0.413 3 466 050
Total 2.403 29 665 080
 
4.5 Diagnostics for the model 
Identifying unusual and influential variables 
The model was checked for outliers and influential observations. In linear regression, an 
outlier is defined as an observation with a large residual8, and the studentized residuals were 
checked for9. A large squared residual indicates that an observation has large differences in 
predicted and actual expenditures on HIV and AIDS. 
 
Leverage points10, when an observation has an extreme value on a predictor variable, can 
have an effect on the estimate of the regression coefficients. Leverage over (2k+2)/n, where 
k is the number of independent variables and n the number of observations e.g. 0.2162 in this 
case, should be examined closer.  
  
As a synthesis of the tests performed, figure 10 gives the leverage-versus-squared-residuals 
plot. The lines mark the means of leverage (horizontal line) and squared residuals (vertical 
line).  
                                                
8 See tables in the annex; A9-A10 
9 A Studentized residual, named in honor of William Sealey Gosset, who wrote under the pseudonym Student, 
is a residual adjusted by dividing it by an estimate of its standard deviation. Studentization of residuals is an 
important technique in the detection of outliers. 
10 See table A11-A12 in the annex 
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Figure 10 Leverage versus squared residual plot to identify the most influential observations 
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Guyana and Swaziland have the greatest leverage, but the model fits the observations very 
well. This is not necessarily a virtue, since high leverage points can control the regression 
coefficients to fit them. The Democratic Republic of Congo, the Czech Republic, Gambia 
and Madagascar have poor fits, but have less influence. Mauritius stands out as an 
observation that is both ill fit and potentially influential. The actual observation on Mauritius 
is 0.1 USD per capita in 2004, which is below average. The estimation for Mauritius is a lot 
higher, meaning that the model predicted Mauritius to spend more than it did. Since their 
HIV prevalence level is around the average with a value of 0.42%, this is probably driven by 
Mauritius being an upper middle-income country with a GDP per capita in the 75th 
percentile, and with a high degree of political stability. 
 
Influential observations can also be measured by specific statistics measuring how much 
each coefficient will change with the removal of a single observation. One such measure is 
DFBETA, which indicates how many standard errors a coefficient would change if 
observation i is deleted. Values in excess of n/2 , which is 0.232 with 74 observations, 
merits further investigation. In figure 11, the two horizontal lines indicate this as the cut off 
line, and the influence of Mauritius is again obvious. Now it is evident that Mauritius is the 
most influential through the variable reg8, the dummy of Sub Saharan Africa, since 
Mauritius is an upper middle income country. This could mean that the model is not as good 
in predicting expenditures of higher income countries in Sub Saharan Africa. Swaziland is 
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influencing the coefficient of HIV prevalence; with a prevalence of 33% it is the country 
with the highest prevalence and far from the mean of 0.68%. Czech Republic is influencing 
the GDP per capita coefficient, and the Democratic Republic of Congo and Gambia are 
influencing the coefficient of political stability, the latter being more political stable than 
average, and the former less.  
Figure 11 The two horizontal lines show values in excess of 74/2  indicating influential observations 
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To check how one observation influences the regression line, the added variable plots (also 
known as partial regression leverage plot or adjusted variable plot) were examined (figure 
12). They depict the relationship between the dependent variable with one of the independent 
variables, adjusted for the effect of the other independent variables. This helps to uncover 
observations exerting a disproportionate influence of the estimated regression model. 
Guyana, with a budget support per capita of 38.6, is showing to be influencing this variable. 
If this observation is deleted, there is almost no change in the coefficient.   
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Figure 12 The added variable plots for all explanatory variables in the final model 
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Checking normality of errors 
The normality of the residuals is required for valid hypothesis testing, but usually it is not 
required to obtain unbiased coefficients of the regression. The residual plot (figure 13) shows 
residuals that seem symmetrically distributed around zero. A symmetric density is necessary 
for normality to hold, but not sufficient, so the plot is not inconsistent with the normality 
assumption. 
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Figure 13 The residual plot 
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A kernel density estimate11 was plotted for the model overlaid by a normal density plot 
(figure 14). This plot seems less coherent with the normality of the errors, the kurtosis is 
almost 4, and the distribution is positively skewed. However, the deviations do not seem too 
substantial. 
                                                
11 A standardized normal probability plot, and a plot with the quantiles of the residuals plotted with the 
quantiles of the normal distribution is found in the annex (figure A5 and A6) 
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Figure 14 The kernel density estimate overlaid by a normal density plot 
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The Shapiro-Wilks test of the null hypothesis that the residuals are normally distributed gave 
a p-value of about 0.002, which shows that we will have to reject the null hypothesis of 
normally distributed errors.  
     
 
Table 14 Shapiro-Wilks test for normal data 
                    
    Variable |    Obs    Skewness    Kurtosis      z     Prob>z 
-------------+------------------------------------------------- 
          e1 |     73    0.93967      3.842      2.934  0.00167 
 
 
 
However, a test for symmetry of the distribution based on inter-quartile range12 gives 
presence of mild and severe outliers (table 15). The presence of severe outliers should be 
sufficient evidence to reject normality at a 5% significance level, while moderate outliers are 
common for any sample size. Table 16 suggests that there are no severe outliers, and the 
distribution seems fairly symmetric, giving evidence that the errors have an approximate 
normal distribution. 
 
 
 
                                                
12 Written by Lawrence C. Hamilton Department of Sociology, University of New Hampshire, the stata 
command being iqr. 
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Table 15 Test for inter-quartile range that assuming symmetry of the residual distribution 
   mean= -5.1e-11         std.dev.=  1.178          (n= 73) 
 median=  .2506    pseudo std.dev.=  1.135        (IQR=  1.531) 
10 trim=  .1203 
                                               low         high 
                                               ------------------- 
                                inner fences   -2.952       3.171 
                           # mild outliers     3           0 
                           % mild outliers     4.11%       0.00% 
 
                                outer fences   -5.249       5.468 
                           # severe outliers   0           0 
                           % severe outliers   0.00%       0.00% 
 
 
Checking for heteroscedasticity of residuals 
Heteroscedasticity of the disturbances was tested with a White test (table A13) and a 
Breusch-Pagan / Cook-Weisberg test (table A14). They test the assumption of a constant 
error variance by examining whether squared standardized residuals are linearly related to 
predicted y. Both test the null hypothesis that the variance of the residuals is homogenous, 
thus a small p-value means that the null hypothesis must be rejected and accept the 
alternative hypothesis that the variance is heterogeneous. The White test has a p-value of 
0.0421, and Breusch-Pagan a more robust p-value of 0.3768. We do not reject the null 
hypothesis in the latter case, suggesting that heteroscedasticity is not a big problem. The tests 
are very sensitive to the models assumptions such as the assumption for normality. 
Therefore they are often used together with the residual plot. Both tests and the residual plot 
indicate heteroscedasticity is not a problem in this model. 
 
Checking for multicollinearity  
When there is a perfect linear relationship among the regressors, the estimates for a 
regression model cannot be uniquely computed. When two variables move together in a 
systematic way, that is when they are near perfect linear combinations of one another, the 
variables are said to be collinear, and when more than two variables are involved the term 
which defines the movement is multicollinearity (Hill et al., 2001:189). The primary concern 
is that as the degree of multicollinearity increases, the regression models estimates of the 
coefficients become unstable and the standard errors for the coefficients can get very 
inflated.  
The variance inflation factor VIF (Stata, 2005) was used to check for collinearity (table 16). 
As a rule of thumb, a variable whose VIF values are greater than 10 may merit further 
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investigation. Tolerance is defined as 1/VIF, a tolerance value lower than 0.1 is comparable 
to a VIF of 10.  
The only problem exists between the dummy variable for Sub-Saharan Africa and the 
interaction term reg8gdp. It could be that they capture the same effect to some extent, but 
they both have high t-values in the model, so they are both kept. Otherwise, there are no 
indications of multicollinearity, and the correlation between political stability and the GDP 
per capita does not affect the model. 
 
Table 16 Variance inflation factor (VIF) to check for multicollinearity, VIF values should not be greater 
than 10. 
Variable VIF       1/VIF   
----------------------- ------------------ 
Sub-Saharan Africa         52.95    0.018885 
reg8gdp 46.96    0.021294 
Logarithm of GDP/cap 3.74     0.267658 
HIV prevalence, adult 
(14-49) 
1.58     0.634773 
Political stability 1.43     0.701288 
Latin America 1.38     0.725110 
Budget support per 
capita                    
1.12     0.895731 
----------------------- ------------------ 
Mean VIF 15.59 
 
 
 
Checking the specifications of the model 
In linear regressions the relationship between the dependent and the independent variable is 
assumed to be linear. In a multiple regression model this can be tested by graphing an 
augmented component-plus-residual plot, also known as an augmented partial residual plot. 
There were no great concerns in these plots, after the logarithmic transformation of GDP per 
capita, but HIV prevalence shows a concave relationship with expenditures rather than a 
linear one (figure 15). However, the pattern does not seem to fit better than the regression 
line, and could be influenced by a few observations. 
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Figure 15 The augmented component-plus-residual plot shows a tendency of unlinearity for the variable 
of HIV prevalence 
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The specification of the model was tested by checking the possibility that the model had an 
omitted variable problem. The Ramsey RESET test (Regression Specification Error Test) is 
designed to detect omitted variables and incorrect functional form (table 17). The test 
examines whether the powers of the fitted values are significant when included in the model. 
Generally the test captures that if we can significantly improve the model by artificially 
including powers of the prediction of the model, then the original model must have been 
inadequate (Hill et. al, 2001:188). Thus, the rejection of the null hypothesis implies that the 
original model is inadequate and can be improved. With a p-value of 0.2548, the null 
hypothesis was not rejected, implying that the test has not been able to detect any 
misspecifications of the model. 
 
Table 17 Ramsey RESET test using powers of the fitted values of logarithm of the domestic public 
expenditures on HIV and AIDS 
       Ho:  model has no omitted variables 
                  F(3, 62) =      1.39 
                  Prob > F =      0.2548 
 
 
A similar method is performed by the command linktest (table 18), introducing the square of 
the predictions to see if the coefficient is significant. The predicted values, _hat, should be 
significant, but the squared predictors, _hatsq, should not if the model is specified correctly. 
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In this model, the squared predictors were not significant, confirming that omitted variable 
bias is not a problem. 
 
 
Table 18 The command “linktest”, testing for omitted variable bias 
      Source |       SS       df       MS              Number of obs =      73 
-------------+------------------------------           F(  2,    70) =   64.62 
       Model |  178.468441     2  89.2342206           Prob > F      =  0.0000 
    Residual |  96.6662522    70  1.38094646           R-squared     =  0.6487 
-------------+------------------------------           Adj R-squared =  0.6386 
       Total |  275.134693    72  3.82131519           Root MSE      =  1.1751 
 
------------------------------------------------------------------------------ 
     lndomex |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
        _hat |   .8140786   .1502499     5.42   0.000     .5144147    1.113743 
      _hatsq |  -.0691583   .0450902    -1.53   0.130    -.1590879    .0207713 
       _cons |   .0426153   .1758232     0.24   0.809    -.3080529    .3932836 
------------------------------------------------------------------------------ 
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5. The predictions 
5.1 Methods 
There are different types of countries in the database, creating different problems. Mainly, 
the prediction problem is addressed in two different ways:  
1. The variable to be predicted is in logarithms. Hence when taking the antilog of the 
predicted logarithmic value, we will on average under-predict the variable of interest. 
This is because of the properties of the natural logarithm, namely its concave 
functional form; Jensens inequality (Sydsæter et al., 1999: section 7.1). 
2. For eleven countries, the database does not include information on domestic public 
expenditures, and predicted values cannot be obtained from the estimated regression 
model because one or more exogenous variables are missing. These variables will be 
replaced by regional means and predictions will be compute with these mean values 
inserted in the estimated regression equation. 
 
The problem with the antilog can be formulated as follows:  
 
Let n be the number of countries, iY  be the observed expenditures on HIV and AIDS, and 
ii YW ln=  the natural logarithm of the expenditures. 
For countries i = 1,, m, observations exists for both iY  and )ln( ii YW = . 
For countries i = m+1,,n, we have unbiased predictions of )ln( ii YW = , but no observations 
on iY  and )ln( ii YW = . To construct an unbiased predictor of i
W
i eY =  for countries i = 
m+1,,n, we proceed as follows:  
Let 
∧∧
= )ln( ii YW  be the predictor of iW  for i = m+1,,n. It is an unbiased estimator of 
∑+=Ε k kikii xXW βα)|( , 
where ),( 1 kiii XXX = . 
Furthermore, 
2)|var()|var( σ== iiii XuXW  
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Assume that the disturbance is normally distributed, that is ),0(~ 2σΝiu . Then we know 
that 
),(~)|( 2σβα ∑+Ν k kikii xXW  
iu
i ev =  & )|()|( i
w
ii XeXY i=  are log-normally distributed. 
We therefore have (Sydsæter et al., 1999: section 32.13) 
2
2
1
)()(
σ
eev iui =Ε=Ε  
and 
2
2
1
)|()|(
σβα +∑+
=Ε=Ε k kiki
x
i
W
ii eXWeXW  
The conclusion is: Replace 
∧
α  by 
2
2
1 ∧∧
+ σα  when predicting iY  from predictions on 
)ln( ii YW = , that is add half of the estimated disturbance variance estimated from 
observations for i = 1,,m to the estimated intercept when predicting the antilog of the log 
transformed left hand side variable for i = m+1,,n. 
 
To solve this problem, the decision was made to add half of the estimated disturbance 
variance to the estimated intercept. The mean square error is the residual or error sum of 
squares divided by the number of degrees of freedom of the sum; it gives an estimate of the 
error or residual variance.  
 
Since the error term, iu , is not exactly normally distributed, and therefore i
u
i ev =  not 
exactly log-normally distributed, these new estimates can be further adjusted using one of 
the properties of the regression predictors. For the countries 1 m, that is for the countries 
with both observations and prediction for the domestic public expenditure on HIV and AIDS 
available, the predictions and the observations should both sum to the same figure. This is 
because of the property that the sum of residuals in linear regressions with Ordinary Least 
Squares always equals zero. That is, had our equations been linear, the problem with the 
estimates would have not occurred. Thus the suggestion is to adjust the predictions with the 
previous estimation method by a ratio, k, of the ratio between the sum of the observed and 
predicted values in countries 1,, m. This way, the sum of the residuals will equal zero and 
this property would again hold.  
That is:  
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Where *iY  is the observed expenditures, and 
∧
iY  the predictions. The ratio k will then be 
multiplied with the estimations for countries m+1, , n thereby adjusting these estimates 
with the same ratio found with countries 1,,m. This will give predictions about 30 percent 
less (k= 0.7036618) than the previous method. 
 
The three-step methods, simply first taking the antilog, next adjusting with the residual 
variance, and finally, adjusting this again with the property of the residuals (k), give three 
different results. The antilogs give the lower bound estimates, and the adjustment with the 
residual variance gives the upper bound. Adjusting with k gives an estimate in between, and 
in the further analysis of the domestic expenditure on HIV and AIDS, these estimates will be 
used for the 46 countries. 
 
Predicted values cannot be obtained from the estimated regression model for eleven 
countries since one or more exogenous variables are missing. The missing values are 
supposed to be NMAR, i.e. not missing at random (Scheffer, 2002:153); the countries with 
no data for say, prevalence or GDP are often poor countries with little or no system for 
collecting statistics. Some of them are also countries in conflict or post-conflict.  Two 
countries, Afghanistan and Iraq, did not even have information on population, and we 
therefore decided to exclude them from the sample for estimation. For the other nine 
countries, GDP and prevalence were the only two missing variables (table 19). These 
missing values were replaced by regional means, even though the regions vary in size. There 
are other, more elaborate, methods to deal with missing data (Scheffer, 2002), but since the 
percentage of countries with missing values are so low, only 0.0714%, the method 
mentioned above was used.  
Table 19 Nine countries for which missing values were replaced by regional means (in green) 
Region countries 
Logarithm of 
GDP 
Budget 
support 
HIV 
prevalence 
Political 
Stability 
CAR  Antigua and Barbuda  9.287 0 1.661 1.127
CAR  Cuba  8.188 0 0.07 0.196
CAR  Dominica  8.241 44.045 1.661 1.014
CAR  Saint Lucia  8.448 2.333 1.661 1.448
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EA  Democratic Republic of Korea  6.885 0 0 0.044
OCE  American Samoa  7.771 0 0.9 0.722
SSA  Seychelles  9.037 1.485 6.915 0.641
SSA  Somalia  6.236 0 0.87 -2.650
WCE  Albania  7.782 9.602 0.07 -0.7857465
 
The regression was then performed with these replacements, yielding predictions for these 
nine countries as well. The same three-step transformations were performed on these 
predictions as for the countries with complete data sets. 
5.2 The predicted expenditures 
The 81 observations we had on domestic public expenditures on HIV and AIDS were 
combined with the 46 predictions from the multiple regression and the nine predictions with 
missing variables, By summing these values, we obtain an estimated total for 136 low- and 
middle income countries. The total estimated expenditures for the countries are 2,744 million 
USD. 
 
The Latin American countries are by far the largest contributors, accounting for about 48% 
of the domestic public expenditures related to HIV and AIDS (Figure 16). Brazil alone spent 
about USD 880 millions in 2004. Sub Saharan Africa spends about 28%, i.e. USD 764 
millions (figure 17), mainly driven by the upper middle income countries such as South 
Africa and Botswana. 
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Figure 16 Total estimated expenditures for 136 low- and middle-income countries 
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Figure 17 Total estimated expenditures for 136 low- and middle-income countries 
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The per capita spending gives a similar picture, but the Caribbean is now higher on the 
ranking. There are big variations between the regions; Latin America spends around 2.6 
USD per capita on HIV and AIDS, while Eastern Asia only spends around ten cents per 
citizen on HIV and AIDS (figure 18). Overall, three regions have reached the one dollar per 
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capita in AIDS expenditures using domestic public funds with the Caribbean being very 
close to this threshold. 
 
Figure 18 Total estimated expenditures per capita for 136 low- and middle-income countries 
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Figure 19 shows that in total, the lower middle-income countries are spending the largest 
amount on HIV and AIDS. However, when taking the size of the population into account, 
the upper middle-income countries has with the highest expenditures on HIV and AIDS 
(figure 20). 
Figure 19 Estimated total expenditures for 136 countries by income level 
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Figure 20 Estimated expenditures per capita for 136 countries by income level 
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Figure 21 visualize how much the observed and estimated values are measuring in totals.  
Figure 21 Total expenditures on HIV and AIDS by source of data 
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A measure often used in analysis of social security to give an indication of performance is 
the expenditures compared to a countrys GDP. In this sense, Sub Saharan Africa is making 
the highest effort with about 0.15% of the GDP going to HIV and AIDS (figure 22). Eastern 
Asia Spends the least as percentage of GDP. From figure 23 we se that upper-middle income 
countries spends the most on HIV and AIDS as percentage of GDP, but the difference from 
what low income countries spend is only about 0.02%. 
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Figure 22 Estimated expenditures as % of GDP 131 low- and middle-income countries, by region 
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Figure 23 Estimated expenditures as % of GDP 131 low- and middle-income countries, by income level 
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6. Conclusion 
In this paper we have presented a regression analysis based on a cross-section dataset for 81 
countries to identify the main determinants of the level of domestic public expenditures on 
HIV and AIDS in low- and middle-income countries. The estimated model was used to 
predict the domestic public expenditures on HIV and AIDS for 2004 for the countries where 
observations on this variable were missing.  
 
From the empirical analysis, four independent determinants for government spending was 
found; GDP per capita (coefficient estimate = 1.256; p<0.001), political stability (coefficient 
estimate = 0.587; p=0.012), HIV prevalence (coefficient estimate = 0.095; p=0.002), and 
budget support per capita (coefficient estimate = 0.059; p=0.017). There are regional 
variations for what determines spending in low- and middle-income countries. The level of 
income is the most influential determinant of the spending, as measured by the size of the 
coefficient in the model, but in the countries in Sub Saharan Africa the political stability is 
more important.  
 
The main finding of the analysis is that combined observations and predictions for domestic 
public expenditures on HIV and AIDS in 2004 amounts to a total of 2.7 USD billions. The 
analysis revealed that there were regional differences in the level of expenditures; Latin 
America  represents about 50% and Sub Saharan Africa represents about 30%. Taking the 
size of the population into account, Latin America still may be said to spend most, with 2.6 
USD per capita, Sub Saharan Africa following with 1.1 USD. It is not unexpected that Latin 
America spends most since all but a few countries are middle-income countries. 
Furthermore, they have well-developed healthcare systems funded largely by governments 
(UNAIDS, 2006:234). 
 
Eastern Asia and Europe has room for improvement when it comes to national effort to 
respond to the HIV pandemic. One striking finding was that Sub Saharan Africa comes out 
with the highest expenditures as % of GDP, and thus can be said to have made the best 
effort. Overall the governments in low- and middle-income countries spend 0.034% of their 
GDP on HIV and AIDS, and they only half a dollar per capita in 2004. However, when 
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comparing the expenditures of regions, Purchase Power Parities should be applied in order to 
really capture that the relatively poorer countries might make a better effort than visible 
without these adjustments.   
 
The aggregated domestic public expenditures for regions are plausible, and in line with 
earlier estimate (Dalen & Reijer, 2006). However, problems might arise when looking at 
each country specifically; Brazil and South Africa are spending more than predicted by the 
model. This could result from the fact that they spend a substantial amount on ART, 
specially the latest years, and ART is not accounted for in the model. Lithuania and other 
Eastern European countries are expected not to be as well explained by the model because 
only two observations from this region were available. When more information from this 
region becomes available, it should be included to improve the predictions for these 
countries. 
 
When attempting to project the domestic public expenditures into the future, a problem that 
may arise is that the determinants as included as regressors in the multiple regression model 
could be difficult to assess or predict for future years when the estimated model based on the 
2004 data is used for this purpose. An assumption might be that theses regressors either 
follow a certain trend estimated from available data, or simply that they remain constant. 
 
Overall, based on our results, we may conclude that the analysis gives an estimation of the 
level of expenditures that should be presented aggregated by regional level. Furthermore, 
when no data is available on expenditures, this analysis provides, to the authors knowledge, 
the best estimate of domestic public expenditures on HIV and AIDS available today. When 
more information becomes available in the form of country-specific time series of the 
relevant variables, and when gaps in the data sets for some countries are filled, the approach 
presented her could be extended to a panel data analysis. In this way we could hope to give a 
better specification of unobserved heterogeneity across countries and to better understand the 
dynamics of the model.
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8. Annex 
Table A1 Variables with number of data points when including the latest year available 
Main variable Proxy Variable 
Countries 
covered 
(2004/2004 and 
latest 
available) 
GDP/cap 131 
GNI/cap 131 
Total debt service (% of GNI) 124 
Amount of money 
available 
Tax revenue (% of GDP) 50/76 
Number of hospital beds (per 10 000 
population) 
41/93 
Nurses (density per 1 000 population) 54/136 
Literacy rate 138 
Physicians (density per 1 000 population) 52/137 
Political stability 137 
Ability to spend the 
money 
Corruption Index 108 
Per capita government expenditure on 
health at average exchange rate (US$)  
138 
Government expenditure on health at 
average exchange rate (US$) as % of 
total health expenditures 
136 
Per capita government expenditure on 
health at international dollar rate  
138 
Per capita total expenditure on health at 
average exchange rate (US$) 
138 
ODA Commitments in 2004 (2004 in 
constant dollars) as share of domestic 
public health expenditures 
135 
ODA Commitments in 2004 (2004 in 
constant dollars) as share of people living 
with HIV 
120 
Number of NGOs in the country 0 
Strategic plan 0 
Commitment/will 
2005 possible composite index from UCC 
survey 
~89 
Estimated number of people living with 
HIV, children (0-14) 
115 Burden of the disease 
Estimated number of people living with 
HIV, adult and children 
127 
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Estimated number of people living with 
HIV, adults (15+) 
126 
HIV prevalence, adult (14-49) 126 
Estimated HIV prevalence, children (0-14) 113 
Number of people with advanced HIV 
infection (urgent need) 
138 (113) 
 
People with advanced HIV infection 
receiving antiretroviral (ARV) combination 
therapy (%) 
124 
Dependent variable 
Domestic public expenditures related to 
HIV/AIDS 
65/81 
 
 
 
Table A2 The correlation matrix shows that political stability has highest correlation with HIV 
expenditures, and that the variables are collinear 
obs=79        
 lndom Political 
Stability 
Voice and 
accountability
Government 
effectiveness
Regulatory 
quality 
Rule of 
law 
Control of 
corruption
lndomex 1       
Political 
Stability 
0.5571 1      
Voice and 
accountability 
0.5275 0.6658 1     
Government 
effectiveness 
0.5179 0.6452 0.7999 1    
Regulatory 
quality 
0.4668 0.6348 0.8082 0.8725 1   
Rule of law 0.4792 0.8033 0.8298 0.8929 0.8465 1  
Control of 
corruption 
0.5271 0.7116 0.8071 0.8829 0.8323 0.9242 1
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 Table A3 Continued  
 hlthshare odashare odaplwh ART child child 
prev 
plwh adult prevalence needART 
Government 
expenditure on 
health at average 
exchange rate 
(US$) as % of 
Total health 
expenditures 
1          
 136          
ODA 
Commitments for 
HIV and AIDS in 
2004 as a ratio of 
domestic public 
health 
expenditures 
-0.11 1         
 135 135         
ODA 
Commitments for 
HIV and AIDS in 
2004 as a ratio of 
people living with 
HIV 
0.20 0.10 1        
 119 118 120        
People with 
advanced HIV 
infection 
receiving 
antiretroviral 
combination 
therapy (%) 
0.16 -0.13 -0.01 1       
 121 120 113 122       
Estimated 
number of people 
living with HIV, 
children (0-14) 
-0.21 0.31 -0.08 -0.20 1      
 114 113 114 108 115      
HIV prevalence, 
children (0-14)  
0.03 0.25 -0.07 -0.06 0.52 1     
 112 112 112 107 113 113     
Estimated 
number of people 
living with HIV, 
adult and children 
-0.22 0.11 -0.07 -0.14 0.82 0.30 1    
 126 125 120 120 115 113 127    
Estimated 
number of people 
living with HIV, 
adults (15+) 
-0.22 0.09 -0.07 -0.14 0.80 0.28 1.00 1   
 125 124 119 119 115 113 126 126   
HIV prevalence, 
adult (14-49) 
-0.01 0.16 -0.09 0.01 0.46 0.95 0.35 0.33 1  
 126 125 119 119 115 113 126 126 127  
number of people 
in need of ART 
-0.19 0.06 -0.07 -0.14 0.83 0.34 0.98 0.98 0.35 1
 112 111 113 106 113 111 113 113 113 113
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Figure A1 The scatter plot reveals that the untransformed GDP/cap has a concave relationship with 
the transformed expenditures rather than a linear one 
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Figure A2 The augmented component-plus-residual plot confirms the concave relationship of the 
GDP/cap and the transformed expenditures  
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Table A4 The forward regression with the significant variables 
                      lndomex     lndomex     lndomex     lndomex    
 
Political stability     1.367***    0.898***    0.812**     0.736**  
                       (0.227)     (0.252)     (0.252)     (0.251)    
 
logarithm of GDP           --       0.634***    0.749***    0.848*** 
                                   (0.178)     (0.168)     (0.173)    
 
HIV prevalence adult       --          --       0.109***    0.111*** 
15-49 years                                    (0.026)     (0.026)    
 
Budget support per c       --          --          --       0.052#   
apita                                                      (0.027)    
 
Intercept              -4.647***   -7.941***   -8.884***   -9.564*** 
                       (0.630)     (1.095)     (1.052)     (1.094)    
 
N                          80          79          74          74    
R2                      0.317       0.415       0.525       0.549    
Adjusted R2             0.309       0.400       0.505       0.522    
*** p<0.001; ** p<0.01; * p<0.05; # p<0.1;  two tailed 
 
 
Table A5 Regression results and joint hypothesis testing of the six dimensions of governance 
      Source |       SS       df       MS              Number of obs =      74 
-------------+------------------------------           F(  9,    64) =   10.40 
       Model |  182.782388     9  20.3091543           Prob > F      =  0.0000 
    Residual |  124.935704    64  1.95212038           R-squared     =  0.5940 
-------------+------------------------------           Adj R-squared =  0.5369 
       Total |  307.718093    73  4.21531634           Root MSE      =  1.3972 
 
------------------------------------------------------------------------------ 
     lndomex |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       lngdp |   .6801085   .2313035     2.94   0.005     .2180266     1.14219 
   budgetcap |   .0282713   .0310812     0.91   0.366    -.0338206    .0903632 
  prevalence |   .1108772    .026416     4.20   0.000     .0581052    .1636493 
    p2olstab |   .8588105   .3611302     2.38   0.020       .13737    1.580251 
       Voice |   .7644409   .4067491     1.88   0.065    -.0481338    1.577016 
  gvrnmnteff |  -.1235399   .8927554    -0.14   0.890    -1.907024    1.659944 
  regquality |   .1453756   .5431219     0.27   0.790    -.9396351    1.230386 
   ruleoflaw |  -1.715947   1.077919    -1.59   0.116    -3.869337    .4374424 
  corruption |   1.121959   .7835789     1.43   0.157    -.4434202    2.687337 
       _cons |  -8.782887   1.818829    -4.83   0.000    -12.41642   -5.149359 
------------------------------------------------------------------------------ 
 
 ( 1)  p2olstab = 0 
 ( 2)  Voice = 0 
 ( 3)  gvrnmnteff = 0 
 ( 4)  regquality = 0 
 ( 5)  ruleoflaw = 0 
 ( 6)  corruption = 0 
 
       F(  6,    64) =    2.67 
  75
            Prob > F =    0.0223 
 
 ( 1)  Voice = 0 
 ( 2)  gvrnmnteff = 0 
 ( 3)  regquality = 0 
 ( 4)  ruleoflaw = 0 
 ( 5)  corruption = 0 
 
       F(  5,    64) =    1.43 
            Prob > F =    0.2246 
 
 
Figure A3 The residual plot of the model without dummy variables  
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Table A6 The 10 lowest and highest observations on the residual before including dummy variables 
  +--------------------+ 
  |         e   region | 
  |--------------------| 
  | -3.405611      WCE | 
  | -2.854148      SSA | 
  | -2.834659      SEA | 
  |  -2.64726      SEA | 
  |  -2.55023      SSA | 
  |--------------------| 
  | -2.178003      SSA | 
  | -1.953101      SSA | 
  | -1.948666      SSA | 
  | -1.738438      SEA | 
  | -1.718504     EECA | 
  +--------------------+ 
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  +-------------------+ 
  |        e   region | 
  |-------------------| 
  | 1.584975      SSA | 
  | 1.657287      SSA | 
  | 1.682247      SSA | 
  | 1.696752      SSA | 
  | 1.711589      SSA | 
  |-------------------| 
  | 1.851469       LA | 
  | 1.907939      SSA | 
  | 2.012213       LA | 
  | 2.053335       LA | 
  | 3.449041      SSA | 
  +-------------------+ 
 
 
Table A7 Stem-and-leaf plot for the residual of the model without dummy variables 
 
e rounded to nearest multiple of .01 
plot in units of .01 
 
 -3** | 41 
 -2** | 85,83,65,55 
 -2** | 18 
 -1** | 95,95,74,72,72,68,62 
 -1** | 36,26,16,13,13 
 -0** | 63,59,56 
 -0** | 47,46,46,44,43,37,33,22,18,17,17,16,14 
  0** | 03,10,11,17,20,29,29,33,33,34,44,47 
  0** | 53,68,73,80,83,83,87,90,96,98 
  1** | 11,12,16,19,20,32,33,42 
  1** | 58,66,68,70,71,85,91 
  2** | 01,05 
  2** |  
  3** | 45 
 
 
Table A8 Inclusion of the different dummies, coefficients and standard errors in parenthesis 
                      lndomex     lndomex     lndomex     lndomex     lndomex    
 
Political stability     0.611*      0.758**     0.600*      0.591*      0.587*   
                       (0.251)     (0.238)     (0.231)     (0.243)     (0.227)    
 
logarithm of GDP        1.122***    0.667***    0.988***    1.474***    1.256*** 
                       (0.210)     (0.175)     (0.197)     (0.250)     (0.244)    
 
HIV prevalence adult    0.072*      0.127***    0.079**     0.095**     0.095**  
15-49 years            (0.031)     (0.025)     (0.029)     (0.031)     (0.029)    
 
Budget support per c    0.058*      0.052*      0.061*      0.056*      0.059*   
apita                  (0.027)     (0.026)     (0.025)     (0.026)     (0.024)    
 
Sub-Saharan Africa      1.094*         --       1.417**     6.400**     5.197*   
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                       (0.501)                 (0.470)     (2.255)     (2.148)    
 
Latin America              --       1.232**     1.463***       --       1.301**  
                                   (0.419)     (0.404)                 (0.407)    
 
reg8gdp                    --          --          --      -0.799*     -0.575#   
                                                           (0.332)     (0.319)    
 
Intercept             -11.488***   -8.683***  -11.009***  -14.110***  -12.948*** 
                       (1.383)     (1.081)     (1.280)     (1.723)     (1.656)    
 
N                          74          74          74          74          74    
R2                      0.578       0.599       0.647       0.612       0.664    
Adjusted R2             0.547       0.570       0.616       0.577       0.628    
*** p<0.001; ** p<0.01; * p<0.05; # p<0.1;  two tailed 
 
 
Figure A4 The logarithm of GDP per capita for Sub-Saharan Africa, and without Sub-Saharan 
Africa 
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Table A9 Stem-and-leaf plot for estud (Studentized residuals) 
estud rounded to nearest multiple of .01 
plot in units of .01 
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 -2** | 97 
 -2** | 68,67 
 -2** | 55 
 -2** | 21 
 -2** |  
 -1** |  
 -1** |  
 -1** | 53,43 
 -1** | 39,35,31 
 -1** | 13 
 -0** | 92,88 
 -0** | 77,76,75,75 
 -0** | 54,54,53,49,42 
 -0** | 39,20 
 -0** | 17,15,09,07,05,01 
  0** | 04,04,07,07,10,11,18 
  0** | 23,26,29,32,36,36,37 
  0** | 40,40,47,54,55,55,56 
  0** | 60,60,68,70,71,72,73,76,78,78,79 
  0** | 83,84,89 
  1** | 02,04,06,10,14 
  1** | 22,30 
  1** | 52 
  1** |  
  1** |  
  2** |  
  2** |  
  2** |  
  2** | 75 
 
 
   
Table A10 The 10 lowest and highest observations on studentized residuals  
  +-------------------------------+ 
  |  studentized         countries | 
  |   residuals                    | 
  |-------------------------------| 
  | -2.967592      Czech Republic | 
  | -2.681854          Madagascar | 
  | -2.665214           Mauritius | 
  | -2.548771   Congo, democratic | 
  | -2.209551          Mozambique | 
  |-------------------------------| 
  | -1.529407         Philippines | 
  | -1.429628           Swaziland | 
  |  -1.38774             Lesotho | 
  | -1.347651                Laos | 
  | -1.314407    Guinea, Republic | 
  |-------------------------------| 
  | .8886309              Senegal | 
  | 1.018214        Guinea-Bissau | 
  | 1.038743         Burkina Faso | 
  | 1.055346               Brazil | 
  | 1.103635                Benin | 
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  |-------------------------------| 
  | 1.139333          El Salvador | 
  | 1.221211                Kenya | 
  | 1.304484             Barbados | 
  | 1.518213             Botswana | 
  | 2.750422               Gambia | 
  +-------------------------------+ 
 
 
Table A11 Stem-and-leaf plot for leverage 
leverage rounded to nearest multiple of .001 
plot in units of .001 
 
  0** | 41,42,44,44,44,45,46,46,47,48,48,49,51,53,53,56,56,56,56,56,57 
  0** | 60,60,61,61,61,61,62,62,64,64,65,65,65,66,67,67,68,69,70,71, ... (30) 
  0** | 80,81,81,81,82,83,83,84,84,87,88,89,90,91,91,92,93,94,94,95, ... (28) 
  1** | 00,00,02,09,15,16,16 
  1** | 20,21,22,23,24,24,27,28,29,38,39 
  1** | 40,42,44,44,47,51,52,54,55 
  1** | 63,63,64,65,69,79 
  1** | 85,87,91 
  2** |  
  2** | 20 
  2** |  
  2** | 68 
  2** |  
  3** | 09 
  3** | 26 
  3** |  
  3** |  
  3** |  
  4** |  
  4** |  
  4** |  
  4** | 77 
 
   
Table A12 The five highest observations on leverage 
  +----------------------+ 
  | leverage   countries | 
  |----------------------| 
  | .2202888       Gabon | 
  | .2683715    Botswana | 
  | .3085434   Mauritius | 
  | .3256772   Swaziland | 
  | .4769459      Guyana | 
  +----------------------+ 
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Figure A5 The standardized normal probability plot 
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Figure A6 The quantiles of the residuals plotted with the quantiles of the normal distribution 
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Table A13 White test for Heteroskedasticity, the null hypothesis being that the residuals are 
heterogeneous 
----------------------------------------------------------------------- 
              Source |       chi2     degrees of freedom      p-value 
---------------------+------------------------------------------------- 
  Heteroskedasticity |      42.13          28                  0.0421 
----------------------------------------------------------------------- 
 
 
 
 
Table A14 Breusch-Pagan / Cook-Weisberg test for heteroskedasticity, , the null hypothesis being 
that the residuals are heterogeneous 
         Ho: Constant variance 
         Variables: fitted values of lndomex 
 
         chi2(1)      =     0.78 
         Prob > chi2  =   0.3768 
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